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ABSTRACT 
 This study investigated the effects of high-fat (HF) diet and chronic endurance exercise 
(Ex) on the regulation of thermogenic capacity in both brown adipose tissue (BAT) and 
subcutaneous (SC) white adipose tissue (WAT), and how it affects whole-body energy 
expenditure (EE). Analysis of tissue mass, PGC-1α and UCP-1 content, presence of multilocular 
adipocytes and palmitate oxidation revealed that HF diet increased the thermogenic capacity of 
BAT, while Ex suppressed it. Conversely, Ex induced the browning of the SC WAT, indicated by 
an increased number of multilocular adipocytes, as well as PGC-1α and UCP-1 content, and 
palmitate oxidation, whereas HF diet attenuated this effect. Despite reducing thermogenic 
capacity of BAT, Ex increased whole-body EE during the dark cycle. We propose that exercise-
induced browning of SC WAT reduces thermogenic capacity in core body regions to manage the 
increased heat production of exercise, and increases it in peripheral regions to adjust metabolic 
rate.  
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1. INTRODUCTION 
 Throughout the past few decades, the prevalence of obesity has increased at an 
alarming rate and continues to grow on a worldwide scale1,2. A sedentary lifestyle in 
combination with poor eating habits results in the hypertrophy and hyperplasia of adipocytes, 
leading to various other metabolic disorders such as type 2 diabetes, coronary heart disease, 
and cancer3,4. In order to prevent these chronic diseases and maintain a stable and healthy 
body weight, the tight regulation of energy intake (EI) and energy expenditure (EE) is required. 
The accumulation of adipose tissue results from an imbalance of EI and EE in which the former 
exceeds the latter, potentially leading to obesity in the long-term. Conversely, weight loss 
occurs when EE surpasses EI causing an energy deficit that is compensated for by the 
mobilization of fat stored in the white adipose tissue. Unfortunately, weight loss is often 
accompanied by the activation of energy-sparing mechanisms that oppose further fat reduction 
and favour the return to initial body weight by decreasing metabolic rate and whole-body 
energy expenditure5. Therefore, the success rate of this therapeutic approach is low. Current 
research is focused on gaining a better understanding of the molecular and metabolic 
mechanisms involved in the development of obesity, and the effective therapies that could 
improve the outcome of obesity and its associated metabolic disorders.  
 It is well-established that there are two types of adipose tissue with unique morphology 
and function identifiable in both human and murine mammals; white adipose tissue (WAT) and 
brown adipose tissue (BAT). The primary function of WAT is to store energy and secrete 
hormones, whereas BAT functions to regulate thermogenesis by dissipating energy in the form 
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of heat6. The presence of BAT allows for high rates of fatty acid and glucose uptake and the 
clearance of plasma lipids, leaving less substrate available for storage in the WAT. Therefore, 
these two tissues play a major role in adjusting energy storage and dissipation, and are of great 
interest to the study of metabolic regulation and whole-body energy expenditure.  
 Importantly, exercise also has profound effects on the regulation of body weight and 
whole-body EE. It is well known that sympathetic nervous system (SNS) activity increases during 
exercise when compared before and after training under conditions of same relative intensity7. 
SNS activity and circulating catecholamines strongly stimulate BAT activity through the 
activation of 3-adrenergic receptors (β3-AR), which leads to an increase in the expression of 
thermogenic genes as well as lipolysis8,9. Since adrenergic receptors in the WAT are also 
stimulated by exercise to increase lipolysis, it has been proposed that exercise may also induce 
the expression of thermogenic genes, in the WAT (a process called "browning"). White 
adipocytes with increased expression of thermogenic genes are called "beige" or "brite" 
adipocytes and display a brown-like phenotype10. Although classical brown adipocytes are 
located in designated depots and have high thermogenic capacity, beige adipocytes found in 
WAT are also capable of dissipating energy in the form of heat and could be potentially used as 
a target for increasing whole-body energy expenditure.   
  Recent studies have provided evidence that endurance exercise can induce browning of 
white adipocytes through a myokine called irisin11. However, exercise in itself is thermogenic 
and it would seem counterintuitive to increase BAT activity and heat production when exercise 
already creates a state of increased body temperature. Although exercise increases SNS activity 
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and circulating hormones that can potentially activate BAT, it has been reported that 
endurance training decreases the oxidative capacity of mitochondria isolated from the 
interscapular BAT (iBAT) of rats12. This provides evidence that chronic endurance exercise 
actually reduces thermogenic activity in classical BAT. Based on these findings, it seems that 
chronic endurance exercise exerts opposite effects on thermogenic capacity of BAT and WAT; 
however, limited information is available regarding this effect. Therefore, the aim of this study 
was to determine the effects of chronic endurance exercise on thermogenesis in classical BAT 
and WAT and the impact on whole-body energy expenditure.  
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2. LITERATURE REVIEW 
2.1 Energy Balance 
 Regulation of body weight is controlled by EI and EE. When EI is higher than EE, there is 
a surplus of energy that leads to an increase in energy stores and weight gain. Conversely, if EE 
is higher than EI, weight loss occurs. Total daily energy expenditure (TDEE) includes basal 
metabolic rate (BMR), thermic effect of food (TEF) and activity thermogenesis (AT).  Adaptive 
thermogenesis may also occur in response to overfeeding or to changes of environmental 
temperature. BMR represents the amount of energy required to sustain vital functions at rest in 
a post-absorptive state and accounts for ~60% of TDEE 13. BMR variance is accounted for by 
body mass and is influenced by the relatively more or less active internal organs and cell type 
metabolism14.  The thermic effect of food (TEF) accounts for 10-15% of TDEE and represents the 
increased EE required to digest, absorb, and store food. Activity thermogenesis accounts for the 
final 25-30% of TDEE and can be separated into 2 components: exercise-related activity 
thermogenesis (EAT) and non-exercise activity thermogenesis (NEAT). While EAT represents the 
amount of energy expended for volitional exercise activities such as sport, NEAT accounts for EE 
required for daily living activities such as sitting, walking, talking, and shopping. Some people do 
not take part in any exercise and therefore their EAT can be close to zero. Thus, NEAT is the 
determining factor of the large variance in activity thermogenesis that contributes to overall 
TDEE. Although it is difficult to measure, NEAT can be estimated by NEAT=TDEE-(BMR+TEF).  
Previous studies have shown that NEAT can increase with a positive energy balance and 
decrease with a negative energy balance. Consequently, NEAT is biologically regulated to adjust 
TDEE and maintain energy balance13.  
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2.1.1. Weight loss and body weight regulation 
 When an individual loses weight, TDEE decreases. In contrast, if an individual gains 
weight, TDEE increases. Individuals who lose 10-20% of initial body weight have significantly 
lower TDEE 15. Alterations in BMR, DIT and AT contribute to these adaptations and counteract 
weight loss through biological mechanisms such as enhanced skeletal muscle efficiency, 
decreased sympathetic nervous system (SNS) tone, and reduced circulating concentrations of 
fat reducing hormones such as leptin, thyroxine, and triiodothryonine5,13,15. Therefore, these 
energy-sparing mechanisms may be the cause of the low success rate of weight loss and it is of 
great interest to find ways to decrease metabolic efficiency or increase TDEE through an 
increased BMR, DIT or AT.  
 
2.2 White Adipose Tissue 
 White adipose tissue (WAT) is the primary organ for triglyceride (TG) storage for use as 
metabolic energy and it also acts as a thermal insulator. The quantity of body fat varies widely 
in mammals and typically accounts for ~20% of body mass in humans and can increase to >50% 
in obese individuals. Such variability demonstrates the delicate balance of factors controlling 
the storage and breakdown of triglycerides. WAT is an essential organ for life and transgenic 
mice without WAT (named A-ZIP/F-1) display adverse physiological consequences such as 
delayed growth, decreased fecundity, premature death, and enlarged organs16. Mice lacking 
WAT are also diabetic and have elevated insulin, glucose,  free fatty acids and triglyceride levels 
16. Although the surplus of WAT is associated with many metabolic disorders such as obesity, 
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the absence of WAT as demonstrated by A-ZIP/F-1 mice indicates that WAT is required for a 
healthy life and contributes greatly to energy metabolism, reproductive function and disease 
susceptibility16.  
 WAT is a highly active metabolic and endocrine organ that is regulated by multiple 
external influences such as autonomic nervous system activity, blood flow, hormones and 
autocrine and  paracrine feedback. WAT possesses the ability to modulate its own metabolic 
activity through hypertrophy of already existing adipocytes, and hyperplasia or differentiation 
of new adipocytes. In addition to its role as an energy storage compartment, adipocytes can 
also secrete endocrine and paracrine factors called adipokines to regulate metabolism in 
peripheral tissues such as the liver and central nervous system17. Ultimately, the amount of TG 
stored within adipocytes is a reflection of net EI:EE, and the pathways of fat storage 
(lipogenesis) and breakdown (lipolysis) are carefully regulated to maintain whole-body energy 
balance 18.  
 
2.2.1. WAT distribution and morphology 
 White adipocytes are unilocular and contain one large lipid droplet that comprises 
majority of the cell surrounded by a layer of cytoplasm and an offset nucleus (Figure 1). It looks 
ivory or yellow in colour and can be found distributed throughout the body. In humans and 
rodents, white adipose tissue can be found under the skin, termed subcutaneous fat; and it can 
also be found surrounding internal organs in the intra-abdominal cavity termed visceral fat. 
Although white fat can be found distributed throughout the body, each depot may have 
7 
 
physiological differences 19. The capacity for triglyceride storage is large as the lipid droplet can 
encompass more than 95% of the entire cell and cell size can fluctuate greatly from 25-200µm 
in diameter 17.  
 
Figure 1: Subcutaneous inguinal fat with H&E staining and microscopic analysis (A). 
Representation of a white adipocyte (B) with one large lipid droplet (LD) and offset nucleus (N).  
 
2.3. Regulation of lipolysis in adipocytes 
 The rate of lipolysis is determined by the actual energy requirements of the body and is 
regulated by hormonal and paracrine and/or autocrine signals. These signals vary in response to 
different physiological situations such as periods of fasting, or exercise, or when glucose stores 
are limited. In order to spare glucose for the central nervous system, fatty acids (FA) become 
the major substrate of energy production for muscles and peripheral tissues and thus, lipolysis 
occurs20,21. In this context, the process of lipolysis is imperative to breakdown the triglycerides 
stored within adipocytes to release glycerol and FA into the plasma. FAs that exit the adipocyte 
are bound to albumin which facilitates their transport through the blood to be utilized for 
oxidation in the skeletal muscle, heart and liver22. WAT lipolysis is regulated by the opposing 
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action of various hormones, mainly catecholamines and insulin and therefore, the net release 
of FA from WAT is determined by the balance between these hormones that stimulate and 
suppress lipolysis, respectively.  
 
2.3.1. Lipolytic pathway 
 In response to fasting or exercise, insulin secretion is decreased and catecholamines 
such as epinephrine and norepinehphrine are released into the blood stream. WAT lipolysis is 
stimulated through direct sympathetic innervation and catecholamines bind to the β-adrenergic 
receptors (β-AdR) located on the surface of adipocytes. On the plasma membrane, β1- and β2-
AdRs are expressed in human WAT, and β3-AdRs are found in rodents19,23. The β-AdR is coupled 
to an intracellular G-protein coupled receptor (GPCR) that activates adenylyl cyclase (AC). The 
effector, AC, then catalyzes the conversion of ATP to cyclic AMP (cAMP). Increased cAMP levels 
bind to the subunits of cAMP-dependent protein kinase A (PKA) and its activation then initiates 
two processes; the phosphorylation and activation of hormone-sensitive lipase (HSL), and the 
phosphorylation, and thus deactivation, of perilipin (PLIN).  Normally, PLIN coats the lipid 
droplet and protects it from lipases in a basal state to maintain lipid content. Once PLIN is 
deactivated, it undergoes a conformational change which allows HSL (in the cytosol) access to 
the lipid droplet, and it also releases comparative gene identification-58 (CGI-58) which is an 
activator of adipose triglyceride lipase (ATGL)24–26.  Once TG mobilization is initiated, ATGL 
hydrolyzes TGs to diacylglycerol (DAG) and HSL breaks down DAG to produce monoacylglycerol 
(MAG) (Figure 2). Finally, MAG lipase (MGL) releases the glycerol backbone and the final FA. 
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Free FA are then released from adipocytes to the circulatory system and are taken up by 
peripheral tissues for oxidation or can be re-esterified into TG9,20,21,27,28. 
 
Figure 2: Schematic representation of catecholamine-induced lipolysis in an adipocyte. 
Catecholamines bind to β-adrenergic receptor (β-AdR) that activates G-protein coupled 
receptor (GPCR) located on the plasma membrane. GPCR activates adenylyl cyclase (AC) that 
produces cyclic AMP (cAMP). High levels of cAMP activate protein kinase A (PKA) that 
phosphorylates hormone sensitive lipase (HSL) and perilipin (PLIN). PLIN releases comparative 
gene-58 (CGI-58) that activates adipose triglyceride lipase (ATGL) that hydrolyzes triglycerides 
(TG) to diacylglycerol (DAG), and HSL hydroyzes DAG to monoacylglycerol (MAG) and MAG 
lipase (MGL) releases the final fatty acid and glycerol. Insulin secretion in a fed state leads to a 
cascade of events that counteracts cAMP production through phosphoidesterase 3B (PDE3B) 
activity.  
 
 The mobilization of FA and glycerol from TG is facilitated in three successive reactions. 
ATGL is responsible for the first step and its importance has been demonstrated in ATGL-KO 
mouse models. Without ATGL, mice displayed substantial TG accumulation throughout the 
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body, leading to cardiac dysfunction and death29,30. In addition, ATGL and CGI-58 gene 
mutations lead to neutral lipid storage disease characterized by systemic abnormal TG 
accumulation in tissues such as bone marrow, skin, and muscle30,31. In response to chronic 
endurance exercise, ATGL expression and HSL phosphorylation increase, resulting in an 
increased lipolytic capacity and higher FA oxidation of the skeletal muscle30.  
 
2.3.2. Anti-lipolytic Pathway 
 Lipolysis can be inhibited by catecholamines that bind to the α-AdRs on the cell surface 
of the adipocyte. The α-receptor signals the inhibitory GPCR (Gi) that blocks the activity of AC 
which leads to the subsequent decrease in cAMP formation and thus lipolysis is inhibited 
downstream (Figure 2). This cascade can also be affected by the presence of insulin.  In a 
postprandial state, exogenous energy sources are available and the need for endogenous 
substrate is reduced, consequently; the breakdown of TG to release FA for fuel is not required. 
The main hormone mediating the suppression of TG breakdown is insulin20,24.  Insulin is a 
potent anti-lipolytic hormone and is released by pancreatic β-cells following a meal. When 
insulin binds to its plasma membrane receptor, it leads to the phosphoryation of insulin 
receptor substrate-1 (IRS-1) on the tyrosine residue and the subsequent activation of 
phosphatidyl inositol 3-kinase (PI3-k). PI3-k then phosphorylates and activates protein kinase 
B/Akt (PKB/Akt), and PKB/Akt phosphorylates phosphodiesterase 3B (PDE3B) which catalyzes 
the degradation of intracellular cAMP28. Consequently, the degredation of cAMP inhibits the 
activation of PKA which leads to the de-phosphorylation of HSL and PLIN and thus, the process 
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of lipolysis is halted21. Furthermore, insulin can also stimulate the re-esterification of FA to form 
TG18,20,26.   
 
2.4. The fate of substrates derived from lipolysis  
 Following the hydrolysis of TG, glycerol and FA can be utilized in extra- and intra-
adipocyte metabolic pathways. Glycerol is not utilized by the adipocyte and is transported out 
of the cell to the plasma by an aquaglyceroporin protein known as aquaporin 7 (Aqp7)32,33. 
Without Aqp7, mice displayed impaired glycerol release and severe fasting-induced 
hypoglycemia34, thus demonstrating the importance of Aqp7 as a glycerol channel. Glycerol in 
the circulation is taken up by hepatic aquaporin 9 (Aqp9) to be utilized as a gluconeogenic 
precursor32.  
 As previously mentioned, FA can be released into the blood and circulating FA bound to 
albumin are taken up FA transporter proteins in peripheral tissues such as skeletal muscle for 
fuel. Any unused circulating FA will return to the adipocyte to be re-esterified into TG35. FAs 
that stay within the cell are either degraded by peroxisomes or channeled towards the 
mitochondria for oxidation. FA are transferred into the mitochondria via the carnitine shuttle 
system and are β-oxidized to yield acetyl CoA for the citric acid cycle (CAC). Following the CAC, 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2) enter the 
electron transport chain (ETC) and electrons released through the ETC results in the pumping of 
protons from the mitochondrial matrix to the inner membrane space. The electric potential 
created across the inner membrane drives the movement of protons back into mitochondrial 
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matrix through the ATP synthase complex and thus, ATP is produced and can be used for 
energy9,14.  
 
2.5. Energy status and AMP-activated protein kinase (AMPK) 
 AMPK is an energy sensing and signalling enzyme that increases ATP production by 
enhancing glucose uptake and fatty acid oxidation in the skeletal muscle and adipose tissue. 
AMPK is a key regulator of energy metabolism and constantly monitors the energy status of a 
cell by sensing changes in intracellular adenosine monophosphate (AMP):ATP ratio brought 
about by exercise or fasting conditions. A decrease in ATP leads to an increase in AMP 
generation that competes with ATP on the Bateman domain of AMPK. The binding of AMP 
induces a conformational change and allows AMPK to be phosphorylated on the threonine 
residue 172 (Thr-172) and thus AMPK becomes active36.  
 
2.5.1. AMPK signaling 
 Due to the variations in energy demands, energy-sensing AMPK plays an important role 
in regulating mitochondrial oxidation. Once activated, AMPK phosphorylates and inactivates 
acetyl-CoA carboxylase (ACC) which leads to the suppression of malonyl-coA production. 
Malonyl coA inhibits inner-mitochondrial membrane protein carnitine palmitoyltransferase 1 
(CPT-1), the rate-limiting step that blocks long-chain FA (LCFA) entry into the mitochondria. 
Thus, when malonyl co-A is reduced, CPT-1 is disinhibited  and LCFA can enter the mitochondria 
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for β-oxidation and subsequently ATP production30,36–38(Figure 3). This is supported by reports 
of marked increases in AMPK phosphorylation and decreased muscle malonyl-coA of rats 
exposed to exercise14,39. Furthermore, chronic AMPK activation also induces the expression of 
perixosome proliferator-activated receptor gamma coactivator 1-alpha (PGC1-α), an important 
transcription factor for mitochondrial biogenesis40. Thus, AMPK up-regulates the oxidative 
capacity of skeletal muscle by multiple mechanisms. Furthermore, the activation of AMPK and 
consequently the entry of LCFA to the mitochondria is also important for the function of UCP-1 
which will be discussed in further detail in a later section.  
 In addition to its role in allowing LCFA into the mitochondria for β-oxidation, AMPK also 
plays an important role in FA oxidation by modulating lipolysis. Some studies have proposed 
that AMPK exerts a pro-lipolytic effect in adipocytes, while others have suggested an anti-
lipolytic effect. AMPK activation has been shown to have an anti-lipolytic effect by 
phosphorylating HSL on a serine residue that antagonizes the phosphorylation of HSL by PKA. 
This mechanism has been proposed to be an energy-sparing mechanism that limits  the 
breakdown of TG in WAT to reduce the potential energy cost of re-esterifying FA that are not 
used41–44. Interestingly, prolonged AMPK activation leads to the prevention of TG storage and 
the promotion of energy dissipation through an increase of ATGL content, decreased 
lipogenesis and increased FA oxidation despite the inhibition of HSL41,44.  When chronically 
activated, AMPK also promotes alterations in gene expression of mitochondrial biogenesis 
markers such as PGC-1α, PPARγ, and CPT-1. By modulating HSL and ATGL in an antagonistic 
manner, AMPK demonstrates a time-dependent function as a cellular energy sensor to regulate 
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the release of FA into the circulation and to upregulate genes that promote lipid utilization 
rather than storage41,44.  
 
Figure 3: An increase in intracellular adenosine monophosphate (AMP) activates AMPK, which  
phosphorylates and inactivates actetyl-CoA (ACC) which suppresses malonyl-coA production. 
Suppressed malonyl co-A production leads to the deinhibition of carnitine palmitoltransferase 1 
(CPT-1) and long-chain fatty acids (LCFA) can enter the mitochondria for β-oxidation. 
 
2.6. Brown Adipose Tissue 
 Throughout history, humans have endured periods of food scarcity and cold weather. 
Fortunately, we have been able to survive these environmental stressors due to the presence of 
adipose tissue. As previously described, WAT acts as an insulator and an energy storage organ 
that allows us to cope with the changing availability of exogenous food sources and varying 
environmental conditions. Another fat depot that has also aided in our survival as a 
thermoregulatory organ is the brown adipose tissue (BAT). BAT was first described in small 
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mammals as a hibernating organ45 and in contrast to WAT, the function of BAT is to regulate 
thermogenesis by dissipating energy in the form of heat6,9,46. Although it was previously 
believed that functional BAT was only found in newborns to survive the cold stress of birth, 
investigators have more recently been able to detect BAT in adult humans using PET/CT scans46.  
 A dual role for BAT  has been proposed; aside from its role as a thermoregulatory organ 
in response to cold, it has also been suggested to function as a metaboregulatory organ in 
response to large caloric loads.  The mitochondria of BAT contain a specialized protein called 
uncoupling protein-1 (UCP-1), which allows for protons to translocate from the intermembrane 
space to the mitochondrial matrix while bypassing the ATP synthase complex (Figure 4). This 
process is called non-shivering thermogenesis and results in the generation of heat, rather than 
ATP46. The high rates of fatty acid and glucose uptake in BAT allow for the clearance of plasma 
lipids leaving less substrate available for storage in the WAT. It has been estimated that basal 
metabolic rate can increase by up to 20% from just 50 g of fully activated BAT 47. Previous 
studies have also shown that there is a negative correlation between the amount of BAT, and 
body fat or BMI 48,49 and animals with more functional BAT were less likely to develop obesity 
and type II diabetes50. This suggests that metabolically active BAT may be of therapeutic value 
for obese individuals and therefore, the thermogenic capacity of BAT is not only important for 
the regulation of body temperature, but also for EE and maintenance of body weight. 
 Importantly, other uncoupling proteins have been discovered in BAT such as UCP-2 and 
UCP-3; however, they are not essential for thermogenesis9,51. In isolated brown adipocytes 
from UCP-1 ablated mice, no thermogenesis could be induced with norepinephrine (NE) nor FA 
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stimulation. In these cells, UCP-2 and UCP-3 were present but did not substitute for UCP-1 as a 
thermogenic protein. This establishes the importance of UCP-1 as the only physiologically 
thermogenic uncoupling protein and that no other mechanisms exist for thermogenesis other 
than the mediation by UCP-19,51.   
 
Figure 4: Schematic representation of a mitochondrion in brown adipose tissue (BAT). Fatty 
acids (FA) and glucose (GLU) undergo β-oxidation and glycolysis respectively, and yield 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2). The 
electron transport chain (ETC) on the inner mitochondrial membrane releases free energy from 
NADH and FADH2 that is used to pump protons from the mitochondrial matrix to the 
intermembrane space. The presence of uncoupling protein-1 (UCP1) allows for protons to leak 
across the inner mitochondrial membrane and uncouples oxidative phosphorylation from 
adenosine triphosphate (ATP) synthesis. Heat is created instead of ATP.  
 
2.6.1. BAT distribution and morphology 
 BAT is highly vascularised and is populated with brown adipocytes containing multiple 
small lipid droplets (multilocular) with a vast number of mitochondria with abundant cristae 
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(Figure 5)52. The tissue appears brown in colour and can be found in various regions throughout 
the body. In rodents, the largest BAT compartments are found between the scapulae (termed 
interscapular BAT, iBAT) and surrounding the aorta (termed periaortic BAT, aBAT). Recent 
research has used 18F-fluorodeoxyglucose (18F-FDG) to trace glucose uptake within the human 
body. An increase in 18F-FDG uptake indicates the presence of active BAT. Using this method, 
researchers have found that human BAT is mostly located in the lower neck and 
paracervical/supraclavicular region19,53. It has also been found in a kite-shaped sheet between 
the scapula of infants46. Brown adipocytes express β-AdR on the surface of the cell and the 
tissue is densely innervated by the sympathetic nervous system (SNS)52.  
 
Figure 5: Brown adipose tissue with H&E staining and microscopic analysis (A). Representation 
of a brown adipocyte (B) with multiple small lipid droplets (LD) and numerous mitochondria. 
The nucleus (N) is round and centrally located.  
 
2.6.2 .Transcriptional control of BAT  
 Prolonged cold exposure is a strong activator of BAT recruitment and function. Cold 
temperatures sensed by thermoreceptors in the skin elicit sympathetic outflow and the growth 
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of blood vessels to facilitate oxygen delivery and heat exchange.  Several transcriptional factors 
that govern BAT development have been discovered including PR domain-containing protein-16 
(PRDM16) and peroxisome proliferator-activated receptor γ-coactivator-1α (PGC-1α)10,54.  
 PRDM16 is highly expressed in BAT and acts by binding to transcriptional factors such as 
CCAT/enhancer binding proteins (C/EBPβ), peroxisome proliferator-activated receptor gamma 
(PPARγ), and peroxisome proliferator-activated receptor alpha (PPARα), and PGC-1α, that are 
important for brown fat differentiation. PRDM16 converts myoblasts and white fat precursors 
into UCP-1 containing thermogenic adipocytes and PRDM16 knockout models show no 
thermogenic characteristics and have an increased expression of white fat genes10. Thus, 
PRDM16 is a critical determinant of BAT lineage during embryonic development. Several factors 
have been shown to modulate brown adipocyte differentiation by regulating PRDM16 
expression and activity, such as bone morphogenetic protein (Bmp7)10.  
 PGC-1α is induced by cold exposure and exercise, and is highly expressed in tissues with 
abundant mitochondrial content such as BAT, liver, and skeletal muscle. It is a master regulator 
of mitochondrial biogenesis and oxidative metabolism, and it directly increases the 
transcription of thermogenic genes such as UCP-155–58. PGC-1α expression and activity is 
directly regulated by the β-adrenergic/cAMP signalling and is phosphorylated and activated by 
p38 mitogen-activated protein kinase (MAPK) in response to sympathetic stimulation. Activated 
PGC-1α regulates the expression of thermogenic genes by interacting with transcription factors 
such as PPARγ. Retinoblastoma family members (pRb and p107) and nuclear co-repressor 
Rip140 repress PGC-1α activity and block the expression of BAT specific genes. Cells lacking 
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PGC-1α can differentiate into mature brown adipocytes, however the induction of thermogenic 
genes in these cells was impaired, indicating that PGC-1α is indeed essential for 
thermogenesis55.  Therefore, thermogenesis is controlled by the positive regulators or 
repressors of PGC-1α transcriptional activity.  
  
2.6.3. β3-Adrenergic signalling is required for thermogenesis  
 All three subunits of β-AdR receptors have been identified in BAT, however, the role of 
β1- and β2-AdRs is not yet well understood. β3-AdRs have the highest expression in BAT and is 
a key player in cell signalling processes9. Transgenic mice that are unable to synthesize 
catecholamines displayed impaired BAT function8 and β-AdR-less mice were thermogenically 
inactive and were unable to maintain body temperature at 4°C. In addition, iBAT taken from 
these mice were large unilocular adipocytes with no UCP-1 and type II deiodinase DIO2 
expression, and oxidation did not increase with pharmacological β-agonist stimulation. 
Interestingly, although food intake between the β-less  and wildtype mice were equal, β-less 
mice exposed to a HF diet developed obesity8,59. These findings confirm the significance of β-
AdR for thermogenic function of BAT and the maintenance of body temperature, as well as for 
the metaboregulatory function of BAT and its defense against diet-induced obesity8. 
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2.6.4. Fatty acids are thermogenic substrates 
 No thermogenesis can occur without first activating lipolysis and all experiments that 
induce lipolysis in BAT also simultaneously induce thermogenesis9. Following the activation of 
β-AdR, lipolysis occurs as previously outlined and FA are released. Some FA may leave the cell 
for fuel for peripheral tissues while remaining FA bound by FA binding proteins in the cytosol 
are channeled towards the mitochondria. Importantly, long chain FAs (LCFAs) are required as 
substrate for β-oxidation and thermogenesis, and they are also involved in the function of UCP-
1. Within the mitochondria, UCP-1 in the resting state is inactive and requires LCFAs to become 
activated. Although the current understanding of the LCFA-dependent mechanism of UCP-1 still 
remains elusive, it has been proposed that an allosteric interaction of FA on UCP-1 leads to its 
activation by overcoming the nucleotide inhibition of UCP-19,60,61. Two other theories of LCFA 
involvement with UCP-1 include its action as a cofactor, and action as a proton shuttle. In the 
cofactory theory, LCFA are localized to binding sites within UCP-1 to act as stepping stones for 
protons as they pass through the membrane. The shuttling theory suggests that protons are not 
transported through UCP-1, but that protons enter the mitochondria by translocating fatty acid 
anions through UCP-19,60,61. Despite multiple theories of how LCFAs are involved with UCP-1 
activation, it is well-accepted that LCFAs or its derivative are directly involved in the 
physiological activation of UCP-1.  
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2.6.5. BAT and diet-induced thermogenesis (DIT) 
Aside from its role as a thermoregulatory organ, BAT has also demonstrated a role in DIT in 
response to high caloric load. Increased heat production during chronic overfeeding is largely 
mediated by BAT thermogenesis. This has been interpreted as defensive mechanism that allows 
the organism to adjust metabolic rate according to energy intake and availability. BAT is 
activated  in rodents after overeating to preserve energy balance and limit weight-gain, 
resulting in DIT10,62. BAT has been shown to undergo hypertrophy accompanied by an increased 
respiration rate63 and blood flow64 following a single meal in rats, and an increased glucose 
uptake after a single meal in humans65. In addition, UCP-1 ablated mice demonstrated no diet-
induced increase in oxygen consumption (VO2), showing that DIT is mediated by the presence 
and activation of UCP-150. Taken together, this data indicates an important role of BAT in the 
overall thermic effect after a meal. 
 
2.7. WAT and BAT plasticity 
 Despite major structural and functional differences between WAT and BAT, both types 
of adipose tissue can acquire features of one another with the appropriate physiological 
stimulus66. Within WAT, clusters of UCP-1 expressing adipocytes with thermogenic capacity can 
develop (a process called "browning"). White adipocytes with increased expression of 
thermogenic genes  are called "beige" or "brite" cells and display a brown-like phenotype10. 
Although classical brown adipocytes are located in designated depots and have high 
thermogenic capacity, beige adipocytes found in WAT are also capable of dissipating energy in 
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the form of heat and consequently, the browning process of WAT has emerged as a potential 
target for the prevention and treatment of metabolic abnormalities.  
 Temperatures below thermoneutrality induce the activation of SNS, a strong stimulator 
for BAT activation. Noradrenaline levels in iBAT were higher in animals exposed to cold 
environments and lower in warm-acclimatized mice. Brown adipocytes from warm-acclimatized 
mice were characterized by a unilocular lipid droplet and did not express UCP-1, demonstrating 
that brown adipocyte function and morphology changes according to physiological stimulus66. 
WAT conversion to BAT has also been suggested by in vitro studies using human Sc tissue.  
PPARγ agonists and PGC-1a transfection induced UCP-1 expression in these Sc adipocytes66,67. 
Taken together, this data demonstrates that the adipose organ is plastic and each depot has the 
ability to take on features of one another. Interestingly, the capacity of inducing beige 
adipocytes in WAT varies within each depot. It appears that the Sc Ing fat depot is more 
susceptible to undergo browning in comparison to visceral fat depots as beige adipocytes are 
found most abundantly within Sc Ing depot of rats10,68,69. In addition, PRDM16, a key driver of 
brown fat cell development, is highly expressed in Sc Ing fat in comparison to other mouse WAT 
depots. A reduction in PRDM16 inhibits the induction of the thermogenic gene program in Sc 
Ing cells resulting in the reduced recruitment of beige adipocytes in WAT. In contrast, 
transgenic over-expression of PRDM16 led to the development of beige adipocyte formation 
within WAT10,68. Primary human subcutaneous adipocytes showed an enhanced BAT-like 
phenotype after FNDC5/FGF21 treatment in comparison to visceral adipocytes70, further 
demonstrating that the induction of a brown phenotype is depot specific.  Additional depot-
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specific traits of WAT have also been proposed- it has been suggested that adipocytes have a 
maximum cell volume in which it cannot further expand by hypertrophy under conditions of 
positive energy balance. The maximum volume, also known as critical cell size, is genetically 
determined and adipocytes that have reached this stage will trigger an increase in cell number. 
It has been reported that visceral fat depots such as the epididymal and mesenteric depots 
have a higher critical cell size and are more prone to hypertrophy while inguinal fat depots are 
more prone to hyperplasia66.  
 
2.7.1. Endocrine factors that induce WAT browning 
 Several factors have been reported to regulate brown and beige adipocyte formation 
and differentiation. Notably, bone morphogenic protein 7 (Bmp7) has proven essential for 
brown fat development. Bone morphogenic proteins are a part of the transforming growth 
factor-β family and were originally thought  to control vital steps of embryonic development 
such as bone formation. However, it has been discovered that Bmps are multifunctional and 
also play an important role in adipogenesis. Although most Bmps such as Bmp2 and Bmp4 
enhance WAT adipogenesis, Bmp7 is unique in inducing brown and beige adipocytes with 
functioning thermogenic capacity through the induction of brown fat regulators such as 
PRDM16 and PGC-1α10,71. Treatment with Bmp7 in preadipocytes led to the initiation of a full 
brown adipocyte transcriptional program marked by significant increases of PPARγ, PRDM16, 
C/EBPs as well as UCP-1. Bmp7 treatment significantly increased PGC-1α as well as nuclear 
respiratory factor-1 and cytochrome C, demonstrating signs of increased mitochondrial 
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biogenesis, an important aspect of brown fat cell development. In addition, there was a 5-fold 
increase in mitochondrial density in Bmp7 treated cells. Taken together, this data demonstrates 
that Bmp7 activates brown adipogenesis  by inducing factors important for brown fat cell 
development and mitochondrial biogenesis. Bmp7 has proven to be a physiological necessity 
for BAT development as demonstrated by Bmp7-knockout mice. At birth, Bmp7-knockout mice 
had 50-70% less iBAT mass in comparison to wild type littermates. In addition, the expression of 
UCP-1 was nearly absent in brown fat from Bmp7-null embryos.  The role of Bmp7 in energy 
homeostasis was also studied in C57BL/6 mice. Injection with adenovirus encoding for Bmp7 
led to a significant increase in brown fat mass with no changes to WAT mass. Moreover, no 
changes to physical activity or food intake were reported but an increase in energy expenditure 
was observed, leading to a significant reduction in weight gain of Bmp injected mice in 
comparison to controls. This establishes an essential role of Bmp7 in brown fat development in 
vivo71.  
 Fibroblast growth factor 21 (FGF21) is a circulating hormone released by the liver to 
stimulate gluconeogenesis and ketogenesis during conditions of prolonged fasting72. In 
response to FGF21 stimulation, differentiated mouse adipocytes and human primary adipocytes 
showed stimulated glucose uptake, and the overexpression of FGF21 in transgenic mice led to 
improved insulin sensitivity and reduced plasma triglyceride concentrations73–75.  In response to 
fasting, FGF21 is secreted to increase lipolysis and the release of FA, which are used for 
oxidation and/or are converted into ketones that can be used by the brain73,74. Importantly, 
FGF21 plays an important role in the regulation of carbohydrate and lipid metabolism, and it 
also seems to affect thermogenesis in classical BAT and WAT following β-adrenergic 
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stimulation. In response to cold exposure, circulating FGF21 and FGF21mRNA levels in BAT 
increased70,76, and treatment with exogenous FGF21 resulted in the up-regulation of brown fat 
genes in human adipocytes70 and promoted thermogenic activity in isolated brown 
adipocytes73. FGF21 administration in ob/ob mice resulted in up-regulation of genes involved in 
lipid metabolism such as UCP-1, PGC-1α, HSL, and ATGL in WAT, and UCP-1 in BAT69,77. In 
addition, these mice showed an increased net energy expenditure, an elevated core body 
temperature, and a reduced total adiposity with no changes in physical activity77. Taken 
together, this may suggest that FGF21 administration led to an increased energy expenditure by 
the induction of metabolically activated adipose tissue77. Interestingly, beige adipocyte 
formation and expression of thermogenic genes were seen in subcutaneous inguinal fat, but 
not epididymal WAT, demonstrating a depot-specific response of FGF21-induced browning. It 
has also been demonstrated that FGF21 expression is induced by BAT and inguinal WAT 
following cold exposure without any changes in liver and circulating levels of FGF2169,76,78. This 
suggests that FGF21 is not only released by the liver, but can also be induced by BAT and WAT 
and acts as an autocrine factor79.  
  Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are key hormones 
released by the heart for regulation of hemodynamic homeostasis, however; they have also 
been shown to promote lipolysis and beige adipocyte development within WAT10,80. 
Comparable to the response of adipocytes to catecholamines, natriuretic peptides activate the 
guanylyl-clyclase containing natriuretic peptide receptor-A that generates the second 
messenger cGMP which activates cGMP-dependent protein kinase in response to cold 
temperatures. Similar to PKA, PKG phosphorylates the same targets as β-agonists and thus 
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lipolysis increases. In human adipocytes, ANP treatment increased PGC-1α and UCP-1 
expression, accompanied by an increased mitochondrial biogenesis and increased respiration. 
BNP infusion in mice robustly increased PGC-1α and UCP-1 expression in both BAT and WAT 
and correspondingly, resulted in an increase in respiration and energy expenditure80.  
 Irisin, another factor secreted by skeletal muscle that regulates the browning of WAT 
will be discussed in further detail in a later section.  
 
2.7.2. Molecular and physiological regulators of beige/brite fat 
 The "browning" process in which white adipocytes change to UCP-1 expressing 
beige/brite adipocytes occurs following thermogenic stimulus such as prolonged cold exposure 
or treatment with β3-agonists. Contrary to previous beliefs, it appears that classical brown 
adipocytes differ in cell lineage when compared to beige/brite adipocytes. Myf5+ progenitor 
cells give rise to skeletal muscles and brown adipocytes, while white and beige adipocytes 
derive from a Myf5- cellular lineage10,54(Figure 6). This suggests that brown adipocytes are 
different from inducible beige adipocytes even at the precursor stage. The molecular 
mechanism that mediates the induction of beige adipocytes in WAT from the Myf5- precursor 
cell involves the up-regulation of PGC-1α and PRDM16. Similar to the differentiation process of 
classical BAT, PRDM16 also interacts with transcriptional factors such as PPARγ, PPARα, and 
C/EBPs, which are key regulators of adipogenesis, to activate the thermogenic program.  
 There is also evidence that white adipocytes have the capacity to convert into inducible 
brown/beige adipocytes through transdifferentiation (Figure 6). After 10 days of cold 
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acclimatization, it was found that the total number of adipocytes in adult female mice were not 
significantly different from mice kept at thermoneutrality. However, the number of brown 
adipocytes in cold-acclimatized mice increased significantly in proportion to the number of 
white adipocytes that were lost. In addition, there was no evidence of apoptosis or mitosis 
which suggests the direct transformation of white to brown adipocytes also known as 
transdifferentiation81.  
WAT and BAT have the ability to acquire metabolic features of one another depending on 
physiological stimulus. Whether this is caused by de novo recruitment of classical BAT or 
transdifferentiation of already mature adipocytes to thermogenic beige adipocytes remains 
unclear.  
 
Figure 6: Schematic representation of the origin of fat cells. Brown adipocytes derive from 
Myf5+ cell lineage precursors and Myf5- precursors give rise to white and beige adipocytes (A). 
In addition, there is evidence of white adipocytes converting to beige adipocytes through 
transdifferentiation (B).  
 
28 
 
2.7.3. Effects of exercise on WAT and BAT plasticity 
It is well documented that endurance training increases PGC-1α content in humans and 
rodents52,82. Human white adipocytes that overexpressed PGC-1α led to an increase in UCP-1 
mRNA expression and FA oxidation67. However, exercise results in a large amount of heat 
production as a consequence of repeated muscle contractions and UCP-1 mRNA and 
thermogenic activity of BAT decrease in rats following exercise83,84. In fact, the oxidative 
capacity of isolated iBAT mitochondria was reduced as a result of endurance training marked by 
reduced levels of cytochrome oxidase activity12. Overall, the reduced thermogenic capacity of 
BAT in response to endurance exercise has been considered physiologically advantageous due 
to the increase in body temperature as a result of chronic exercise in the trained state.  
Physiologically, SNS activity and circulating catecholamines strongly stimulate BAT activity 
through the activation of 3-AdR, which leads to an increase in the expression of thermogenic 
genes as well as lipolysis 8,9. It is well known that SNS activity increases during exercise when 
compared before and after training under conditions of same relative intensity7, however; 
thermogenic capacity of BAT following exercise is decreased regardless of the increased SNS 
activity. It has been previously demonstrated that prolonged exposure to β-AdR receptor 
agonist, Ro16-8714, selectively down-regulates β3-AdR, marked by a decreased in β3 mRNA 
and loss of receptor number in brown adipocytes85. This down-regulation by β-AdR agonists 
suggests the possibility that prolonged exposure to β-adrenergic stimulation through chronic 
endurance exercise can also down regulate  β3-AdR expression in classical BAT. Interestingly, 
when mice were stimulated with a β3-agonist,  CL316243, UCP-1 positive brown adipocytes 
29 
 
appeared within the Sc Ing fat pad but not in the visceral fat depot; this indicates a depot-
specific response to browning86. 
Since adrenergic receptors in the WAT are also stimulated by exercise to increase lipolysis, it 
has been suggested that exercise may also induce the expression of thermogenic genes in the 
WAT. This mechanism has been proposed to be induced by a PGC-1α-dependent myokine 
called irisin.  Irisin is cleaved from the ectodomain of fibronectin-domain containing protein 5 
(FNDC5) produced in the skeletal muscle during exercise and is released into the circulation to 
signal white adipocytes in Sc tissues to undergo browning11. In humans, serum irisin levels were 
higher after submaximal exercise in comparison to maximal exercise, suggesting that endurance 
exercise as a more potent stimulator of irisin release following exercise70. However, the role of 
irisin in exercise-induced browning of Sc Ing fat has been challenged. As expected, in vitro 
contraction of human myotubes induced PGC-1α expression, however FNDC5 mRNA was not 
altered. In addition, muscle biopsies from human participants also showed no differences in 
FNDC5 expression in response to exercise87. Therefore, the discrepancy of findings across 
studies indicates a possible alternative mechanism behind the browning of Sc Ing fat. 
Interestingly, it has been reported that FNDC5 and irisin increase in Sc fat following exercise 
and consequently, irisin has also been proposed to behave as an adipokine88,89.  
In murine mammals and humans, classical BAT is highly vascularised and is found close to 
the heart so that the heat produced can be effectively distributed throughout the body. In 
response to chronic endurance exercise, body temperature rises as exercise is thermogenic in 
itself. As a consequence, it seems physiologically relevant for BAT thermogenesis to decrease to 
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avoid overheating.  Importantly, Sc Ing fat is located peripherally and an increase in beige 
adipocytes within this fat depot may increase energy dissipation without increasing core body 
temperature. Therefore, the browning of Sc Ing fat may be important for the regulation of WAT 
metabolism and whole-body energy expenditure in response to chronic endurance exercise. It 
has been demonstrated that adipose-derived stromal/progenitor cells (hASCs) taken from 
human Sc WAT can efficiently be converted into beige adipocytes with functioning 
characteristics of typical brown adipocytes90. This exhibits the possibility that humans can 
convert WAT to beige adipocytes upon stimulation and is a potential target for alter whole-
body energy expenditure.  
 
2.8. Significance of WAT/BAT plasticity and its effect on whole-body energy expenditure 
 Up until a few decades ago, it was assumed that adult humans had too little brown fat 
to substantially affect body weight. However, recent imaging studies have revealed the 
presence of extensive depots of brown fat in adults46,91. Converting white into brown 
adipocytes gives rise to the possibility of dissipating energy beyond thermogenesis of classical 
BAT depots and holds tremendous promise for the treatment of obesity and its associated 
metabolic diseases.  
 Upon the discovery of UCP-1 and its energy dissipating capabilities, chemical 
mitochondrial uncoupling using 2,4-dinitrophenol (DNP) has been tried as a weight-loss 
therapy. Similar to activated UCP-1, DNP works as a chemical uncoupler that allows protons to 
leak across the mitochondrial membrane, utilizing FA and glucose and leaving less substrate for 
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storage in WAT. However, high doses of unregulated respiratory uncoupling causes deleterious 
side effects including hyperthermia and death10. Ideally, strategies should be developed to 
enhance respiratory uncoupling selectively in adipose tissue.  Further studies are required to 
determine the molecular mechanisms that can increase BAT activity in a safe and effective 
manner. 
 The discovery of β3 agonists such as CL316243 have shown remarkable anti-obesity and 
anti-diabetic effects in rodents and has induced the BAT phenotype in WAT86,92. Despite of this, 
the physiological relevance to humans of β-agonists is limited. To date, the pharmaceutical 
industry has not been successful in developing a safe and effective β-agonist that is highly 
specific to adipose tissue, and the risk of side effects to other organs containing β-receptor 
subtypes is substantial.  Poor pharmacokinetic properties and oral bioavailability are also 
obstacles10 and the number of β3-AdRs in human WAT seems to be lower in humans and thus, 
the efficacy of a β3-AdR agonist is minimal9,18. 
 Taken together, the data in this literature review suggests that both WAT and BAT are 
very plastic tissues with the ability of acquiring metabolic features of one another depending on 
the physiological stimulus, such as exercise, diet, and cold exposure. Further studies are 
required to determine the molecular mechanisms that affect WAT and BAT plasticity and holds 
tremendous possibilities in hopes to treat obesity.  
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3. OBJECTIVES AND HYPOTHESIS 
 Currently, there is no clear consensus regarding the effects of chronic endurance 
exercise on the thermogenic capacity of BAT and WAT. Therefore, the objective of this study 
was designed to determine the effects of chronic endurance exercise on thermogenesis in 
classical BAT and WAT and the impact on whole-body energy expenditure.  
 Based on the current concept that chronic endurance exercise decreases the oxidative 
capacity of isolated mitochondria from BAT, and that endurance training may promote 
browning of WAT, I hypothesize that chronic endurance exercise will decrease the overall 
thermogenic capacity of classical BAT and increase thermogenic capacity of WAT. Furthermore, 
I hypothesize that these adaptations will lead to an overall increased whole-body EE.   
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4. STATEMENT OF LABOUR 
 All experiments conducted in this study were carried out in equal contribution by 
Michelle Victoria Wu (MVW) and George Bikopoulos (GB). MVW's involvement included 
exercise training of animals, collection of food intake and body weight data, extraction of 
tissues, western blotting of adipose tissue samples, and palmitate oxidation. Due to the logistics 
of this experiment, the co-author of this manuscript is GB. Daily measurements of food intake 
and body weight, training of animals, extraction of tissues and palmitate oxidation experiments 
were equally shared responsibilities between GB and MVW. In addition, GB was also involved in 
the preparation of tissues for microscopy and determination of serum irisin levels. Validation of 
the PGC-1α antibody was also required by the reviewers of the manuscript and GB and MVW 
conducted additional experiments that are not included in the thesis. These experiments 
involved knock-down of PGC-1α in L6 muscle cells, which were conducted by GB. Also, western 
blots to probe for PGC-1α in tissues of PGC-1α knockout mice and PGC-1α overexpressing mice 
which were required by the reviewers, were conducted by MVW.  Additional assistance was 
required from Steven Hung, who has completed his MSc. Degree in Dr. Ceddia's lab at York 
University. His contribution was essential in the collection of blood from animals under strict 
YUACC guidelines, and he also aided in western blotting experiments of muscle samples.  
 Dr. Rolando Ceddia is the primary investigator and supervisor of this project and this 
research was funded by the Natural Sciences and Engineering Research Council of Canada 
(NSERC) grant 311818-2011.  
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5. MATERIALS AND METHODS 
5.1. Reagents – Fatty acid free bovine serum albumin (BSA), L-carnitine and CoA and palmitic 
acid were purchased from Sigma (St. Louis, MO). DTT, ATP, ADP and nicotinamide adenine 
dinucleotide phosphate (NADP) were obtained from Bioshop Canada Inc. (Burlington, ON). [1-
14C] palmitic acid was purchased from GE Healthcare Radiochemicals (Quebec City, QC). The 
irisin kit was purchased from Pheonix Pharmaceuticals (Burlingame, CA). cOmplete ULTRA 
tablets and phosStop inhibitors were purchased from Roche Diagnostics (Mannheim). Specific 
antibodies against ATGL, AMPK, P-AMPKThr172, and β-actin were purchased from Cell 
Signalling Technology Inc. (Beverley, MA). The PGC-1α antibody was from Millipore (Temecula, 
CA) and the antibodies against UCP-1 and FNDC5 were purchased from abcam (Cabridge, MA).  
 
5.2. Experimental Procedures –  Male Wistar rats had ad libitum access to a low-fat (LF) diet or 
high-fat (HF) diet. Food intake (FI) and body weight (BW) measurements were taken on a daily 
basis, and blood was extracted every 2 weeks. Additionally, in vivo metabolic parameters such 
as energy expenditure (EE), respiratory exchange ratio (RER) and ambulatory activity was 
measured at the end of the 8 week protocol. By the end of the study, muscle and adipose tissue 
was extracted for further analysis and lean body mass was determined. Important proteins for 
thermogenesis (UCP-1, PGC1-) were analyzed in adipose tissue, and oxidative capacity ex vivo 
was also measured. This experiment was designed to identify the thermogenic adaptations of 
adipose tissue in response to endurance training and the potential molecular mechanisms that 
alter whole-body energy homeostasis. All experimental procedures were approved by the York 
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University Animal Care Committee, permit number: 2011-14, and were carried out under strict 
YUACC guidelines. All surgery was performed under Ketamine/Xylazine anesthesia, and all 
efforts were made to minimize suffering.   
 
5.3. Animals –  Male albino rats of the Wistar strain from Charles River Laboratories, weighing 
~200g (initial weight) were used for this experiment. Upon arrival, the animals were given 1 
week to acclimatize to the new environment prior to initiating any of the experimental 
procedures. In order to assign each animal to an experimental group, the rats were subjected to 
an exercise protocol selection process to determine rats unwilling to exercise. The screening 
process consisted of 3 separate treadmill exercise sessions. Each session started with a 5-min 
warm-up period set at a constant 5% inclination and 10m/min speed. Following the warm-up, 
the inclination was raised to 10% and remained constant while the speed was increased by 
2m/min every 2 min up to 30m/min. Any rats unwilling to run were excluded from this study. 
Only 10% of the animals did not meet the inclusion criteria.  Animals that ran for the longest 
duration of time were then selected and randomly assigned to one of four experimental 
groups; Sedentary (Sed) LF, Exercise (Ex) LF, Sed HF, and Ex HF. The rats were kept in a constant 
23°C temperature environment with a fixed 12-hour light(07:00-19:00)/12-hour dark 
cycle(19:00-07:00) with ad libitum access to water and either low-fat (LF) diet (10% fat, 70% 
CHO, and 20% protein) or high-fat (HF) diet (59.9% fat, 20.1% CHO, and 20% protein) obtained 
from Research Diets Inc. Animals were housed in individual cages so that FI and BW could be 
measured daily.  
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5.4. Exercise Protocol –  In order to determine the initial training protocol, specialized 
treadmills connected to the Comprehensive Laboratory Animal Monitoring System (CLAMS) 
from Columbus Instruments were used to conduct maximal oxygen consumption (VO2 max) 
tests at week 0, 2, 4, and 6 of the study. Animals were continuously monitored while running an 
incremental speed and inclination protocol until exhaustion was reached. Exhaustion was 
characterized by the rats remaining on the shock pad for longer than 5 consecutive seconds, or 
at which point oxygen consumption (VO2) did not increase, or if the RER reached a value of 1. 
See Table 1 for the VO2 max protocol. Animals in the exercise groups were subjected to 1 hour 
of treadmill running at 70-85% VO2 max, 5 days a week for 8 weeks and the exercise protocol 
was adjusted accordingly to maintain exercise intensity throughout the study. At the beginning 
of the study, the average speed was 24m/min and progressed to 42m/min by week 8. Animals 
in the sedentary groups were also placed on the treadmills at a speed of 2m/min for 1 
hour/day, 5 days a week for 8 weeks to ensure equal conditions.  
 
Table 1. VO2 max protocol 
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5.5. In vivo metabolic parameters –  The CLAMS was also used to perform all in vivo 
measurements of VO2, carbon dioxide production (VCO2), spontaneous ambulatory activity and 
RER. Ambulatory activity was measured by a system of infrared beams that detect animal 
movement. Respiratory exchange ratio was calculated by the ratio of VCO2 to VO2 (RER=VCO2/ 
VO2). A lower RER (0.7) indicated greater fat oxidation, while a higher RER (1.0) indicated 
greater carbohydrate oxidation. Energy expenditure (heat) was calculated by multiplying the 
calorific value (CV= 3.815+1.232x RER) by VO2.  Measurements using the CLAMS were 
performed at week 8 of the diet and exercise protocol, 24 hours after the last exercise bout and 
animals were kept in the CLAMS for 25 hours. The first hour was discarded as the time required 
for the rats to acclimatize to the new cage environment and the remaining 24 hours were 
monitored encompassing the light (07:00-19:00 h) and dark cycle (19:00-07:00 h). 
 
5.6. Tissue extraction and organ mass –  Following the 8 week endurance exercise and diet 
protocol, animals were dissected 48 hours after the last bout of exercise to ensure that all 
results were a consequence of chronic endurance exercise and not from an acute exercise bout. 
Animals were weighed and anesthetized (Ketamine/Xylazine, 0.4mg and 8mg/100g BW). SC 
inguinal (Ing) WAT, epididymal (EPID), retroperitoneal (RETRO), iBAT and aBAT were carefully 
excised and weighed. A portion of each adipose tissue depot were used for palmitate oxidation 
and another portion immediately snap frozen for further analysis. A scalpel was used to detach 
the entire skin of the animal including the head and weighed separately. The abdominal and 
thoracic cavity was incised longitudinally which exposed internal organs that accounted for the 
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viscera. Lean body mass (LBM) was measured by weighing the remaining carcass consisting of 
skeletal muscle, bones, and the skinned head, liver, heart and kidneys.  
 
5.7. Irisin determination in the serum – Blood was extracted immediately after exercise at 
week 6, and also during resting conditions at week 8 of the study. For resting irisin levels, blood 
was collected from the saphenous vein 24h after the last bout of exercise, in a fed state. For the 
determination of irisin immediately after exercise, blood was collected from the saphenous vein 
immediately after running for 1h at 70-85% VO2 max for exercise trained animals, and after 
exposure to the treadmill for 1h at 2m/min for sedentary animals. Irisin was determined using 
the ELISA Kit from Pheonix Pharmaceuticals Inc. 
 
5.8. Palmitate oxidation – After extraction, samples of soleus (Sol) and extensor digitorum 
longus (EDL) muscles (~100 mg), and iBAT and aBAT (~100 mg), and SC Ing fat (~300 mg) were 
thoroughly minced in ice cold SETH buffer (300 mM sucrose, 2 mM EDTA, and 10 mM Tris-HCL, 
pH 7.4). The solution was then homogenized in an ice-cold Potter-Elvehjen glass homogenizer 
and 400 l of the tissue homogenate was transferred to plastic scintillation vials containing 
1.6ml reaction mixture (150mM sucrose, 5mM MgCl2, 30mM kcl, 30mM potassium phosphate 
buffer, 2mM EDTA, 2mM ADP, 15mM Tris-HCl, 1% BSA, 0.75mM palmitate, 1mM 
carnitine,.25mM CoA, pH7.4) containing 0.2 Ci/ml [1-14C] palmitic acid. Cold and 14C-labeled 
palmitate were complexed with fatty-acid free bovine serum albumin (BSA) before being added 
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to the reaction mixture. Within the plastic scintillation vial, an isolated eppendorf tube 
containing a loosely folded filter paper was moistened with 2-phenylethylamine/methanol (1:1 
vol) to collect 14CO2. After 1 hour of incubation at 37°C, the media was acidified with 200 l of 
sulphuric acid (5N) to release 14CO2. Scintillation vials remained sealed for another hour of 
incubation.  Subsequently, the filter papers were transferred to scintillation vials for 
radioactivity counting of 14C. Rates of palmitate oxidation were measured by the production of 
14CO2 from the [1-
14C] palmitic acid. 
 
5.9. Adipose tissue morphology – Upon extraction of each fat pad, small samples (~50-100 mg) 
of each fat depot was removed for microscopy. Within Sc Ing WAT, two samples were collected; 
one from the upper portion of the tissue, and another from the middle portion of the tissue 
with a visible brown appearance. Samples were fixed in 4% paraformaldehyde, 0.1 M 
phosphate buffer solution (pH 7.4) and stored at room temperature for 24 hours. Tissues were 
then washed and stored in 70% ethanol and subsequently sent to the Toronto Centre for 
Phenogenomics for sectioning and hemotoxylin and eosin (H&E) staining. In order to prevent 
biased selection of cells and cell measurement for the determination of average adipocyte area, 
two independent investigators measured 3 randomly selected fields of view of 150 cells for 
each animal. 
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5.10. Western blot analysis – Upon extraction, adipose tissues were immediately snap frozen in 
liquid nitrogen and homogenized in lysis buffer [25 mM Tris-HCl, 25 mM NaCl, 1 mM MgCl2, 2.7 
KCl, 1% Nonidet P-40, and protease (cOmplete ULTRA tablets)  and phosphatise (PhosStop) 
inhibitors (pH 7.4)]. Homogenates were centrifuged for 10min at 16,000 rpm at 4°C and the 
infranatant was collected. An aliquot of each sample was used to determine protein 
concentration using the Bradford method. Samples were diluted 1:1 with Laemmeli sample 
buffer [62.5mM Tris-HCl, pH 6.8; 2% (wt/vol) sodium dodecyl sulfate; 50mM DTT; 0.01% 
(wt/vol) bromophenol blue] and heated at 95°C for 5 min before loading onto sodium dodecyl 
sulfate-polyacrylamide gel (SDS-PAGE), and then transferred to polyvinyl difluoride (PVDF) 
membranes (Bio-Rad Laboratories). Aliquots of cell lysates containing 10-50µg of protein were 
used to determine the content of UCP-1 (33kDA), PGC-1 (113kDA), total AMPK, phospho-
AMPK Thr172 (62kDA), ATGL (54kDA), GAPDH (36kDA), FNDC5 (22kDA) and -actin (45kDA). Blots 
were scanned and the density was determined using the ImageJ Program. The values 
(expressed as arbitrary units) were obtained by dividing the density of the band of interest by 
either β-actin or GAPDH from the same blot (as indicated by figure legends). Similarily, P-AMPK 
was normalized by total AMPK.  
 
5.11. Statistical analyses – Graph Pad Prism 5 was used for all statistical analyses. The 
significance of differences between two groups was determined by a two-tailed Student’s t-
test, and by one-way or two-way ANOVA for multiple comparisons. A Bonferroni post-hoc test 
was used when differences were identified.  
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6. RESULTS 
6.1. Effects of endurance training and high-fat diet on body mass, LBM, and adiposity –  Body 
mass of Ex LF and Ex HF rats was 12% lower than Sed LF and Sed HF controls (Table 2). LBM of 
Ex LF and Ex HF rats were also reduced by 7% in comparison to Sed LF and Sed HF animals 
(Table 2). In Ex LF and Ex HF animals, the masses of Epid, SC Ing, and Retro fat pads were 
significantly reduced by 33% and 30%, 40% and 26% and by 42% and 37% respectively, when 
compared to Sed LF and Sed HF controls (Table 2). As expected, HF feeding significantly 
increased adiposity in all three fat pad masses by 1.73-. 1.3- and 1.86- times in Sed HF animals 
when compared to Sed LF controls (Table 2.) Endurance training prevented this increase in 
adiposity induced by HF feeding. Epid, Sc Ing, and Retro fat pads of the Ex HF animals were 
similar to Sed LF controls (Table 2).  
 
Table 2. Effects of chronic endurance exercise training and high-fat diet on body mass, 
adiposity, and LBM. Measured at the end of the study. 
 
 
42 
 
6.2. iBAT mass and assessment of unilocular droplet area – iBAT mass significantly increased 
with HF feeding (1.84-fold) when comparing Sed HF animals to Sed LF animals (Figure 7A and 
C). Chronic endurance exercise reduced iBAT mass by 39% and 26% when comparing Sed LF to 
Ex LF, and Sed HF and Ex HF animals, respectively (Figure 7A and C). Microscopic analysis 
revealed that iBAT extracted from Sed LF and Sed HF animals displayed typical multilocular 
brown adipocytes, while Ex LF and Ex HF animals displayed larger unilocular lipid droplets 
resembling adipocytes normally found in white adipose tissue (Figure 7B). In fact, unilocular 
adipocyte area was 3-fold higher in iBAT taken from an Ex LF animal than a Sed LF animal, and 
1.84-fold higher in Ex HF than Sed HF animals (Figure 7D).  
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Figure 7. Chronic endurance training and high-fat (HF) diet exert antagonistic effects on mass 
and unilocular lipid content in the interscapular brown adipose tissue (iBAT).  (A) iBATs 
dissected from sedentary (Sed) or endurance exercise trained (Ex) rats, fed either a low-fat (LF) 
or HF diet.  (B) Microscopic images (20x magnification) of H&E staining of iBAT samples. (C) 
Average iBAT mass and (D) unilocular adipocyte area of all four groups. *p0.05 vs. Sed LF; # 
p0.05 vs. Sed LF, Ex LF, Ex HF; † p0.05 vs. Ex LF; $p0.05 vs. Sed LF, Sed HF; ‡ p0.05 vs. all 
other conditions. Two-way ANOVA (n=8).  
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6.3. PGC-1 and UCP-1 content and palmitate oxidation in iBAT and aBAT – PGC-1 and UCP-1 
contents of iBAT and aBAT were increased by 3.5-fold and 2.55-fold, and by 3.38-fold and 2.21-
fold when compared to Sed LF rats, respectively (Figure 8A-F). Conversely, animals in the Ex LF 
group revealed a reduction in PGC-1 and UCP-1 content by 69% and 63% and by 79% and 45%, 
respectively, when compared to Sed LF animals. Importantly, chronic endurance exercise 
completely attenuated the HF-diet induced effect of increased PGC-1 and UCP-1 in iBAT and 
aBAT (Figure 8A-F). A similar trend was found in palmitate oxidation of iBAT and aBAT. 
Palmitate oxidation decreased by 65% and 72%, and by 45% and 51% in iBAT and aBAT, 
respectively, when comparing Ex LF and Ex HF animals to Sed LF and Sed LF animals and 
increased in iBAT (2-fold) and aBAT (2.5-fold) of Sed HF rats when compared to Sed LF controls 
(Figure 8G and H). These results indicate that chronic endurance exercise reduces, and HF 
feeding increases thermogenic capacity of iBAT and aBAT.  
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Figure 8. Interscapular and aortic brown adipose tissue (iBAT and aBAT, respectively) were 
extracted from sedentary (Sed) or endurance-trained (Ex) rats fed either a low-fat (LF) or high-
fat (HF) diet. Ex and HF diet increases PGC-1 and UCP-1 content, as well as palmitate oxidation 
in iBAT and aBAT. Representative blots (A, B) and densitometric analysis of PGC-1 (C, D), UCP-
1 (E,F) contents, and palmitate oxidation (G, H) in iBAT and aBAT. -actin was used as loading 
control for all western blot experiments. *p0.05 vs. Sed LF; # p0.05 vs. all other conditions. 
One-way ANOVA (n=8). 
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6.4. Morphological analysis and mean adipocyte area of the Sc Ing fat depot – Upon visual 
analysis of the Sc Ing fat depot, the middle region of the tissue was browner in animals exposed 
to chronic endurance exercise than sedentary animals, although the upper extremity of the 
tissue remained white (Figure 9A and B, G and H). Samples of the upper and middle regions of 
the tissue were used for H&E staining, as indicated by the black circles (Figure 9A and B, G and 
H). It was found that the middle and upper regions of the Sc Ing fat from Sed LF (Figure 9C and 
D) and Sed HF Figure 9I and J) rats contained unilocular adipocytes, typical of WAT. The upper 
extremities of the Ex LF (Figure 9E) and Ex HF (Figure 9K) animals also contained typical white 
adipocytes, but interestingly, the middle region of the SC Ing fat depot taken from an Ex LF 
(Figure 9F) and the Ex HF (Figure 9L) animal showed the appearance of multilocular adipocytes, 
typical of what is seen in BAT. Furthermore, when comparing the middle regions of the SC Ing 
fat depot between Ex LF and Ex HF animals, the former contained a much larger area occupied 
by multilocular brown adipocytes (Figure 9F and L). These findings suggest that chronic 
endurance exercise induced the browning of SC Ing fat, and HF feeding attenuated this effect. It 
is also to be noted that the mean adipocyte area taken from the upper extremity of the SC Ing 
fat depot was significantly higher in the Sed HF animal than all other conditions (Figure 10A). 
Intriguingly, this robust increase in mean adipocyte area of Sed HF animals was not seen in the 
middle region of the Sc Ing fat (Figure 10B). Additionally, the mean adipocyte area in the middle 
region of the fat depot was also reduced by 30% in Ex LF rats and by 36% in Ex HF rats when 
compared to their SED LF and SED HF controls (Figure 10B). These findings suggest that the 
adipocytes located in the middle region of the Sc Ing fat pad are not only capable of inducing a 
brown-like phenotype, but are also resistant to HF feeding induced hypertrophy.  
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Figure 9. Chronic endurance training induces browning and the presence of multilocular 
adipocytes in the subcutaneous inguinal (SC Ing) fat depot of low-fat (LF) and high-fat (HF)-fed 
rats. Left and right SC Ing fat depots taken from sedentary (Sed) and endurance trained (Ex) rats 
fed either a LF (A, B) or HF (G, H) diet for 8 weeks. Samples from the upper extremity and 
middle region of the SC Ing fat depots, as indicated by the black circles, were used for H&E 
staining and microscopy analysis. Representative images (20x magnification) of adipocytes from 
Sed (C, D) and Ex (E, F) rats fed a LF diet and Sed (I, J) and Ex (K, L) rats fed a HF diet are shown. 
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Figure 10. Chronic endurance training reduces mean adipocyte area in the upper (A) and middle 
(B) region of the subcutaneous inguinal (SC Ing) fat depot. High-fat (HF) feeding increases mean 
adipocyte area only in the upper region. Samples of the upper and middle regions of the SC Ing 
fat depot (as indicated in Figure 3) were taken from sedentary (Sed) or endurance trained (Ex) 
rats fed either a low-fat (LF) or high-fat (HF) diet.  *p0.05 vs. Sed LF; # p0.05 vs. all other 
conditions. One-way ANOVA (n=8). 
 
6.5. PGC-1, UCP-1, and ATGL content, AMPK phosphorylation, and palmitate oxidation in 
the Sc Ing fat depot – In order to determine whether or not the middle region of the Sc Ing fat 
depot actually contained functional brown adipocytes, important proteins involved in 
thermogenesis and oxidative capacity of the tissue was measured. PGC-1, UCP-1, and ATGL 
content, and AMPK phosphorylation were increased in Ex LF animals by 9.1-fold (Figure 11A 
and B), 6.13-fold (Figure 11A and C), 4.84-fold (Figure 11D and E), and 3.8-fold (Figure 11F and 
G), respectively, when compared to Sed LF animals. PGC-1, UCP-1, and ATGL content, and 
AMPK phosphorylation also increased in Ex HF animals when compared to Sed LF controls, but 
to a much lesser extent than what was seen in Ex LF animals (Figure 11A-H). In Sed HF rats, 
PGC-1 was down-regulated by 78% and UCP-1 was almost undetectable. No alterations were 
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observed for ATGL content or AMPK phosphorylation in Sed HF rats when compared to Sed LF 
controls. These findings are compatible with palmitate oxidation results in which oxidative 
capacity of Ex LF animals was 3.35-fold higher than Sed LF controls, and no significant 
alterations were apparent between Sed HF rats and Sed LF animals. Taken together, these 
findings indicate that chronic endurance exercise induced the browning of Sc Ing fat and the 
appearance of these brown-like adipocytes was accompanied by functional thermogenic 
adaptive responses. Conversely, HF feeding attenuated these effects.  
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Figure 11. The middle region of subcutaneous inguinal (SC Ing) fat was extracted from 
sedentary (Sed) or endurance trained (Ex) rats fed either a low-fat (LF) or high-fat (HF) diet. 
Chronic endurance training and high-fat (HF) diet reduces PGC-1 (A,B), UCP-1 (A,C), and ATGL 
(D,E), contents, as well as AMPK phosphorylation (F,G), and palmitate oxidation (H) of the SC 
Ing fat depot. -actin was used as loading control for all western blot experiments. *p0.05 vs. 
Sed LF; # p0.05 vs. all other conditions. One-way ANOVA (n=8). 
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6.6. UCP-1 content in visceral fat depots – We also wanted to test whether exercise also 
induced the browning of visceral fat depots. Upon visual inspection, there was no browning 
that occurred in neither Epid, nor Retro fat pads. We also we measured UCP-1 content in both 
fat pads (Figure 12). UCP-1 was not detected under any of the experimental conditions 
indicating that Sc Ing fat was the only WAT depot that underwent browning under chronic 
endurance exercise conditions. 
 
Figure 12. Neither endurance exercise (Ex) nor high-fat (HF) diet affected UCP-1 content in both 
the epididymal (Epid) and retroperitoneal (Retro) fat depots. The Epid and Retro fat pads were 
extracted sedentary (Sed) or Ex rats fed either a low-fat (LF) or HF diet. -actin was used as 
loading control for all western blot experiments. A sample of interscapular brown adipose 
tissue (iBAT) containing 10g of protein was used as a positive control for UCP-1. Samples of 
Epid and Retro fat pads contained 50g of protein.  
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6.7. PGC-1α and FNDC5 content and palmitate oxidation in soleus muscles – PGC-1α content 
increased by 2.5-, 3.45-, and 3.58- fold in soleus muscles from Ex LF, Sed HF, and Ex HF rats 
when compared to Sed LF rats (Figure 13A and B). No significant differences were found in 
FNDC5 content in soleus muscles across all experimental conditions (Figure 13A and C). 
Palmitate oxidation results showed a 2.4-, 2.1-, 2.45- fold increase in Ex LF, Sed HF, and Ex HF 
rats respectively, when compared to Sed LF rats (Figure 13D). Similar findings for PGC-1α, 
FNDC5, and palmitate oxidation were found for EDL muscles (data not shown). Together, these 
findings indicated that chronic endurance exercise caused a robust training effect in skeletal 
muscle; however, it did not affect FNDC5 content in these tissues.  
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Figure 13. Soleus muscles extracted from sedentary (Sed) or 8-week endurance-trained (Ex) rats 
fed either a high-fat (HF) or low-fat (LF) diet were assayed for PGC-1α content (A and B), FNDC5 
content (A, C), as well as palmitate oxidation (D). GAPDH was used as loading control. *p0.05 
vs. Sed LF; # p0.05 vs. all other conditions. One-way ANOVA (n=8). 
   
6.8. Circulating irisin and FNDC5 content in Sc Ing fat – Circulating irisin levels did not differ 
among the four experimental groups under resting conditions at week 8 (Figure 14A), nor 
immediately after exercise at week 6 (Figure 14B). Following the 8 week chronic endurance 
exercise and HF diet protocol, animals fed a HF diet seemed to have lower levels of circulating 
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irisin when compared to those on a LF diet. However, these values did not reach statistical 
significance. FNDC5 content of Sc Ing fat from Ex LF animals significantly increased, while the 
content in Sed HF animals was markedly reduced (Figure 14C and D). Exercise seemed to 
attenuate the affect of HF diet and raised FNDC5 content of Ex HF animals to levels similar to 
the SED LF controls (Figure 14C and D).  
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Figure 14. Serum irisin levels measured under resting conditions 24h after the last bout of 
exercise at week 8 (A), and immediately after exercise at week 6 (B). Chronic endurance 
exercise increases FNDC5 content in subcutaneous inguinal (SC Ing) fat (C and D). The middle 
region of the SC Ing fat depot was used for the determination of FNDC5 content. -actin was 
used as loading control. *p0.05 vs. Sed LF; # p0.05 vs. all other conditions. One-way ANOVA 
(n=8). 
 
6.9. 24-hr ambulatory activity and energy expenditure – There were no significant differences 
in ambulatory activity and energy expenditure across all four groups during the light cycle 
(Figure 15A-D) However, there was a significant decrease (23%, 29%, and 35%) in ambulatory 
activity of Sed HF animals when compared to Sed LF, Ex LF, and Ex HF animals, respectively, 
during the dark cycle (Figure 15A and B). In addition, energy expenditure analysis revealed a 
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significant increase of 14.2% in Ex LF rats, and 17.8% in Ex HF rats when compared to Sed LF 
animals during the dark cycle (Figure 15C and D). The increase in energy expenditure of Ex LF 
and Ex HF animals is not due to alterations in ambulatory activity as this variable was not 
changed during the dark cycle.  
 
 
Figure 15. Effects of chronic endurance training (Ex) and high-fat (HF) diet on spontaneous 
physical activity and whole-body energy expenditure. 24 hour measurement of ambulatory 
activity (A, B) and energy expenditure (C, D) at the end of the 8 week endurance exercise 
protocol. The rats were allowed to rest for 24hrs prior to being placed in the Comprehensive 
Laboratory Animal Monitoring System (CLAMS) from Columbus instruments. *p0.05 vs. Sed LF; 
# p0.05 vs. all other conditions. Two-way ANOVA (n=8). 
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7. DISCUSSION 
 The findings of this study revealed that thermogenesis is antagonistically regulated 
under conditions of chronic endurance exercise and HF feeding in classical BAT and SC Ing WAT 
which is important for the regulation of whole-body energy expenditure. Energy surplus 
through a HF diet increased the mass, PGC-1 and UCP-1 contents and palmitate oxidation in 
iBAT and aBAT, while in Ex LF animals, these variables were markedly reduced. These results are 
compatible with our findings that endurance training caused an accumulation of unilocular 
adipocytes in iBAT and aBAT, indicating reduced thermogenic capacity in these tissues.  
Conversely, the middle portion of the Sc Ing fat depot of Ex LF animals displayed higher levels of 
PGC-1, UCP-1, and ATGL content, along with increased AMPK phosphorylation and palmitate 
oxidation, and HF feeding attenuated these effects. These molecular changes in combination 
with the observed  presence of UCP-1-positive multilocular adipocytes in the Sc Ing tissue of Ex 
LF animals indicated an increased thermogenic capacity. These findings are in agreement with 
previous studies in which exercise induced the browning of WAT11,92.  In addition, the middle 
region of the Sc Ing fat depot was more responsive to browning induced by exercise than the 
upper region. In fact, the middle region of the Sc Ing tissue displayed an increase in multilocular 
adipocytes, UCP-1 content, and rate of oxidation when exposed to chronic endurance training. 
These observations were not found at the proximal or distal extremities of this fat depot. 
Furthermore, the mean adipocyte area in the extremities of the Sc Ing fat increased in Sed HF 
animals, whereas the middle region of the fat depot remained unchanged. This indicates that 
the middle portion of the Sc Ing fat is not only capable of browning induced by exercise, but it is 
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also resistant to adipocyte hypertrophy induced by HF feeding. These results are compatible 
with the site-specific differences in thermogenic capacity we found in the Sc Ing fat depot in 
rats. Previous studies in mice have reported major depot- and strain-specific differences in UCP-
1 expression, indicating that the Sc Ing fat depot is more prone to acquiring a brown-like 
phenotype than visceral fat depots 10,11,81,86. In this study, we demonstrated that exercise-
induced browning of WAT in rats is also depot-specific, since we found an increased UCP-1 
content and the presence of multilocular adipocytes in Sc Ing WAT but not in Epid or Retro WAT 
in response to exercise.  
 Previous studies have shown that moderate to high intensity endurance training 
increases SNS activity and circulating catecholamines7 and importantly, BAT activity is strongly 
stimulated by catecholamines 8,93. In our study, VO2 max tests were conducted every two weeks 
and training intensity for endurance exercise animals was kept at a constant 70-85% 
throughout the study, so circulating catecholamines were expected to increase during exercise. 
Despite of this, thermogenic capacity of BAT and WAT were antagonistically regulated. Chronic 
heat exposure from exercise seemed to override the catecholamine-induced BAT activity 
normally observed in centrally located fat depots by decreasing thermogenic capacity of iBAT 
and aBAT, but not in peripheral body regions such as the Sc Ing fat depot. It is unclear whether 
these antagonistic effects are due to a different distribution of α- and β-adrenergic receptors 
and catecholamine response, or by other exercise-induced factors independent of 
catecholamines. 
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 In this context, previous studies have suggested that exercise induces the browning of 
Sc Ing WAT by stimulating the release of a PGC-1α-dependent myokine called irisin. Irisin has 
been proposed to derive from the cleavage of the FNDC5 receptor under exercising conditions 
and results in the browning and increased UCP1 expression in subcutaneous adipose tissue11 . 
In order to assess whether circulating irisin could mediate the exercise-induced browning effect 
found in this study, we measured circulating irisin levels and FNDC5 content. We found that 
chronic endurance exercise and HF diet both caused robust increases in PGC-1α content and 
palmitate oxidation in Sol and EDL muscles. However, we did not detect any significant 
alterations in FNDC5 content. Furthermore, circulating irisin levels under resting conditions 
were unaffected by endurance exercise and HF feeding. It is possible that irisin increased 
transiently after exercise and values obtained under resting conditions may have missed such 
an effect. Therefore, we also measured circulating irisin levels immediately after exercise at 
week 6 of the study. We found no significant differences across all four groups of animals. Our 
findings are compatible with other studies reporting lack of muscle FNDC5 and irisin release 
after exercise 87,94. It has also been reported that FNDC5 and irisin can be released by 
adipocytes 89, therefore, we also measured FNDC5 content within the Sc Ing fat depot. Similar 
to PGC-1α and UCP-1 content, chronic endurance exercise significantly increased FNDC5 
content, while HF diet markedly reduced it. These findings suggest that locally produced FNDC5 
in the adipose tissue rather than circulating irisin could have mediated the browning effect seen 
in the Sc Ing fat depot following exposure to chronic endurance exercise.  
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 Exercise is thermogenic in itself and a large amount of heat is produced as a 
consequence of repeated muscle contractions. Thus, a reduction in BAT activity is expected and 
has been demonstrated in previous studies84. Our findings were consistent with this since iBAT 
and aBAT had reduced UCP-1 content and oxidative capacity as a consequence of chronic 
endurance exercise. This result can be explained by the adaptive response to down-regulate 
thermogenesis in response to chronic exercise-induced heat production. Besides exercise and 
cold temperature, structural and functional alterations in BAT are also regulated by diet-
induced thermogenesis (DIT) 47,95,96. In mice, UCP-1 ablation eliminated DIT and the animals 
developed obesity when living at thermoneutrality 50. In addition, it has been reported that 
glucose uptake in BAT increases after a meal in humans 65. These studies indicate the role of 
BAT in reducing metabolic efficiency and increasing energy expenditure. In our study, the 
increased thermogenic capacity of iBAT and aBAT in sedentary animals exposed to HF diet is 
also compatible with the adaptive response of increased DIT under conditions of energy 
surplus.   
 Regular exercise is often prescribed to facilitate and maintain weight loss2,97. This study 
confirms that chronic endurance exercise reduces body weight through a reduction in adiposity 
and LBM. In the final week of training, ambulatory activity and EE were measured. There were 
no significant alterations in spontaneous ambulatory activity, yet energy expenditure of Ex LF 
and Ex HF animals was 14.2% and 16.8% higher, respectively, when compared to Sed LF 
controls during the dark cycle. Despite having a decreased iBAT and aBAT thermogenic capacity, 
the resting EE of endurance trained animals was significantly higher than controls. It appears 
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that the browning of Sc Ing fat could have contributed to this increase in EE as demonstrated by 
the increase in UCP-1 content and palmitate oxidation found in the endurance-exercised 
animals. However, it seems paraxodical for the body to facilitate the browning of Sc Ing fat and 
increase thermogenesis when chronic endurance exercise is already thermogenic in itself. It has 
been proposed that exercise-induced browning of Sc Ing fat could have evolved from shivering-
related muscle contractions in response to cold stress. When shivering occurs, muscle 
contractions lead to the release of myokines that allow the browning of white fat, and in this 
context, muscle contractions due to exercise could also lead to the release of hormones that 
activate adipose thermogenesis11,70. In our study, the rats lived in thermoneutral environments 
and were not exposed to cold stress. Typically thermogenic tissues such as iBAT and aBAT 
displayed a decrease in mass, UCP-1 content, and oxidative capacity when exposed to chronic 
endurance exercise. Therefore, it seems unlikely that the browning of the Sc Ing fat depot 
occurred in order to enhance non-shivering thermogenesis and increase heat production. 
Instead, this response suggests a compensatory mechanism in which the body induces 
browning of Sc Ing fat depots to regulate whole-body energy expenditure in response to the 
decreased BAT mass and activity in core regions.  
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8. CONCLUSIONS 
 When comparing the thermogenic capacity of classical BAT and WAT fat depots, the 
effects of exercise are paradoxical. In fact, the opposite responses seen in BAT and WAT to 
chronic endurance exercise and HF diet prove to play a very important role in regulating whole-
body energy expenditure. Our results demonstrated that the thermogenic capacity of WAT and 
BAT is antagonistically regulated by chronic endurance exercise and HF diet, and the alterations 
seen in these animals may reflect a compensatory mechanism in which the browning of Sc Ing 
fat occurs to allow the organism to regulate whole-body energy homeostasis in response to the 
decreased thermogenic capacity of BAT located in the central core area. This is characterized by 
a reduction in thermogenic capacity of classical BAT, accompanied by the browning of Sc Ing fat 
in response to chronic endurance exercise. This shift of thermogenic capacity from core regions 
to peripherally located tissues may allow the organism to adjust whole-body energy 
expenditure by activating thermogenesis when required, while simultaneously coping with the 
chronic heat production induced by exercise. These novel findings also raised the following 
question: How does the antagonistic effect of exercise on classical WAT and BAT affect whole-
body energy expenditure? Our in vivo findings demonstrated that there were no differences in 
ambulatory activity, however; the energy expenditure of exercised animals were significantly 
higher than the sedentary controls. Not only this, but the animals in the chronic endurance 
exercise groups showed smaller BAT mass and lower thermogenic capacity. Therefore, the 
higher energy expenditure seen in these animals could be explained by the browning of Sc Ing 
fat observed in animals exposed to exercise. Therefore, even though the metabolic alterations 
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to classical BAT and WAT in response to exercise seem paradoxical, they may be of great 
physiological relevance in regards to whole-body energy expenditure. Collectively, our results 
provide novel evidence that the browning of Sc WAT may play an important role in regulating 
whole-body energy expenditure and could potentially be used as a therapeutic approach to 
treat obesity and its related metabolic disorders.  
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9. FUTURE DIRECTIONS 
 In our study, we observed that exercise exerts an antagonistic effect on thermogenic 
capacity of brown and white adipose tissue. The mechanisms that lead to this paradoxical effect 
remain to be determined.  It is well understood that lipolysis is controlled by the activation of β-
receptors during exercise-induced increases in catecholamine release, and the rate of lipolysis 
is regulated in two ways; 1.) the variation in the regulating signal and 2.) the variation in 
responsiveness to the regulating signal. The density of receptors found in each adipose tissue 
depot vary to a great extent20. Obesity is associated with a decreased lipolytic effect in 
response to catecholamine stimulation due to alterations in adrenergic signaling pathways21.  
Our results could be conferred by similar adaptive responses that affect the distribution of α- or 
β-receptors and catecholamine release within each fat depot in response to exercise and HF 
diet.  Therefore, the aim of my future studies is to determine whether chronic endurance 
exercise changes the distribution of adrenergic receptors or NE release in classical BAT and Sc 
Ing WAT.  
 
9.1. Distribution of adrenoreceptors in different fat depots 
 Adrenoreceptors play a crucial role in the regulation of TG storage within adipocytes. 
The combination of α- and β-Ad receptors mediate the lipolytic response of adipose tissue to 
catecholamines. When the body requires increased energy or rate of heat production, a signal 
is transmitted via the SNS and NE is released from local nerve endings. NE binds to β-AdR that 
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are coupled to a G-stimulatory protein that activates AC which will then catalyze the conversion 
of ATP to cAMP. Increased cAMP levels lead to the activation of PKA which then initiates two 
processes; the phosphorylation and activation of HSL and the phosphorylation, and thus 
deactivation, of PLIN.  These two steps are vital for the breakdown of  TG to free FA which are 
used as acute substrate for thermogenesis, and importantly to regulate UCP-1 activity. 
Conversely, α-AdR are coupled with G-inhibitory protein, which inhibits AC activity and 
decreases cAMP levels and thus reduces the rate of lipolysis downstream 9,27. The balance 
between adrenoreceptor subtypes regulates lipolytic drive and thus, is an essential factor for 
thermogenesis. There are species-and depot-specific differences in the expression of 
adrenoreceptor subtypes that modulate to fat cell function 23. In this context, one major 
objective I wish to address in my future studies is to examine any distribution differences of α- 
and β-Ad receptors in the BAT and WAT, and importantly within the different regions of Sc Ing 
fat. The exercise-induced browning response was only seen in the middle portion of the Sc Ing 
fat, indicating a possible variance of adrenergic receptor distribution in comparison to the 
upper extremity. A higher expression of β-AdR found in the middle portion of the Sc Ing fat 
could theoretically have resulted in an increased rate of lipolysis which could have allowed for 
the increased thermogenesis seen in our results. Thus, it is important to investigate the 
combination of α- and β-AdR that mediate the lipolytic effect of catecholamines, and 
consequently alter the thermogenic capacity of different fat depots. In order to confirm our 
hypotheses, we will assess the distribution of α- and β-receptors in each type of tissue by 
measuring their protein content through western blot analysis.  
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9.2. Catecholamine release in different fat depots 
 In addition to the various adrenoreceptors expression in each type of fat, the amount of 
catecholamines released at nerve endings is also an important determinant of lipolytic activity 
and thermogenic capacity. Catecholamines such as NE, attach to binding sites on fat cells 
according to the affinity of each adrenoreceptor subtype. It has been proposed that α-AdR 
inhibit lipolysis at rest with low levels of catecholamines, whereas β-AdR modulate lipolysis 
when exposed to high levels of catecholamines such as physical exercise. During exercise, high 
NE concentrations maximally stimulate β-AdR which mask the inhibitory actions of α-AdR 98. 
This supports the idea that NE may exert dual actions in the cell depending on the 
concentration of NE available at the adipocyte level 23.  In fact, it has been demonstrated that 
catecholamines play different roles in lipolysis at rest and during exercise in human 
subcutaneous fat tissue 98. Therefore, it would be interesting to investigate the amount of 
catecholamines, specifically NE, released by nerve endings in both types of tissue. 
 It is well known that exercise transiently increases SNS activity, and catecholamine 
release stimulates BAT thermogenesis 8,9. Surprisingly, in the present study, we see that 
exercise reduces thermogenic capacity of BAT and increases it in specific portions of the WAT. It 
could be possible that chronic exercise mediates the amount NE released in the BAT versus the 
WAT. To confirm our hypothesis, we will assess the capacity of NE release in each fat depot by 
measuring Tyrosine hydroxylase (TyrH) and dopamie-β-hydroxylase (dβH), which are essential 
enzymes for catecholamine synthesis. Low levels of TyrH or dβH will signify a decreased 
capacity to synthesize NE. This information will further elucidate the regulation of 
thermogenesis in classical BAT and WAT in response to exercise.  
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11. APPENDICES 
11.1. Appendix A: Detailed Experimental Methods 
 
11.1.1. Determination of irisin in the serum using ELISA kit from Pheonix Pharmaceuticals 
(CAT#EK-067-29) 
This Enzyme Immnoassay Kit contains an immunoplate pre-coated with a secondary antibody 
and the non-specific binding sites are blocked. The secondary antibody can bind to the primary 
peptide antibody that is also bound with biotinylated peptide and peptide standard. The 
biotinylated peptide interacts with streptavidin-horseradish peroxidise (SA-HRP) that catalyzes 
the substrate solution (containing 3,3',5,5'-te-tramethylbenzidine, TMB) and hydrogen peroxide 
that produces a blue solution. Adding hydrochloric acid (HCl) stops the enzyme-substrate 
reaction and the solution turns yellow. The intensity of the yellow colouring is directly 
proportional to the SA-HRP amount and inversely proportional to the amount of peptide in the 
samples. A standard curve of known concentration is established first and the unknown 
concentration of the samples can be determined by extrapolation of the standard curve.    
Kit Reagents 
1. 20x assay buffer concentrate 
2. 96 well immunoplate 
3. Acetate plate sealer (APS) 
4. Primary antibody  
5. Standard peptide 
6. Positive control 
7. Biotinylated peptide 
8. Streptavidin-horseradish peroxidise (SA-HRP) 
9. Substrate solution (TMB) 
10. 2N HCl 
Note: Kit components must be equilibrated to room temperature before starting the assay. 
After rehydration, use solutions as soon as possible.  
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Preparation of peptide standard solutions 
Standard # Standard Vol. 1x Assay Buffer Concentrations 
Stock 0 1000 µl 1000ng/ml 
#1 100 µl of Stock 900 µl 100ng/ml 
#2 100 µl of #1 900 µl 10ng/ml 
#3 100 µl of #2 900 µl 1ng/ml 
#4 100 µl of #3 900 µl 0.1ng/ml 
 
Protocol 
1. Dilute 20x assay buffer concentrate (50mL) with 950ml of ddH20. This will make it a 1x 
assay buffer solution. Use this solution to dilute or dissolve all other reagents.  
2. Centrifuge and rehydrate the standard peptide with 1ml of 1x assay buffer. Vortex. 
Now, the concentration of this stock solution is 1000ng/ml. Allow solution to sit at room 
temperature to be completely dissolved. Vortex and centrifuge immediately before use.  
3. Centrifuge and dilute samples with 1x assay buffer. Different samples may require 
different dilution factors to ensure samples are within dynamic range of the standard 
curve.  
4. Centrifuge and rehydrate positive control with 200µl of 1x assay buffer, primary 
antibody with 5mL of 1x assay buffer, and biotinylated peptide with 4ml of 1x assay 
buffer. Allow solutions to sit for 5 mins to completely dissolve and mix well. 
5. Leave A1 and A2 empty as blanks. 
6. Pipette 50µl of 1x assay buffer into B1 and B2 as total binding. 
7. Add 50µl of prepared peptide standards into wells in duplicates. 
8. Add 50µl of positive controls in duplicates. 
9. Add 50µl of samples into designated wells in duplicates.  
10. Add 25µl of primary antibody into each well EXCEPT the blank well 
11. Add 25µl of bitinylated peptide into each well, EXCEPT the blank well 
12. Seal the immunoplate with APS. Incubate for 2 hours at room temperature on an orbital 
shaker. 
13. Centrifuge SA-HRP vial and pipette 12µl into 12mL of 1x assay buffer to make SA-HRP 
solution. Vortex vigorously.  
14. Remove APS from immunoplate, discard contents of the wells.  
15. Wash each well with 1x asay buffer, discard the buffer, invert and blot dry. Repeat 4 
times 
16. Add 100µl SA-HRP solution into each well. 
17. Reseal immunoplate with APS. Incubate for 1 hour at room temperature on orbital 
shaker.  
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18. Remove APS from immunoplate, discard contents of the wells. Wash and blot dry 
immunoplate 4 times again.  
19. Add 100µl TMB substrate solution into each well. Reseal plate with APS. Incubate for 1 
hour at room temperature on orbital shaker. Protect immunoplate from light at this 
point. 
20. Remove APS from immunoplate, add 100µl 2N Hcl into each well to stop the reaction. 
The colour should change from blue to yellow and gently tap plate to ensure thorough 
mixing.   
21. Load immunoplate onto Microplate reader and read absorbance O.D. at 45nm.  
 
 
Results 
Standard curve should show a reverse sigmoidal shape and is constructed by plotting the 
known concentrations on the X-axis and cooresponding O.D. reading on the Y-axis.  
The standard curve shows an inverse relationship between O.D. absorbance and peptide 
concentration. As standard concentration increases, the yellow colour intensity should 
decrease which results in a reduced O.D. absorbance.  
 
The concentration of the peptide in each sample is determined by locating the O.D. of each 
sample on the Y-axis and the a horizontal line should intersect with the standard curve. At this 
point, a vertical line will intersect the X-axis to show corresponding peptide concentration of 
the sample.  
Note: if the samples were diluted prior to the assay, the concentration calculated must be 
multipled by the dilution factor.  
 
The final results are expressed as irisin (ng/ml) 
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11.1.2. Complexation of Palmitate  
1. Prepare 30mL of SETH Buffer (Recipe found in palmitate oxidation buffers section) 
2. Add 3.75g FA-free BSA (Sigma Cat# A3803) to get a 12.5% solution 
3. Heat to 50°C in water bath  
4. Take 1600mg palmitic acid (Sigma Cat# P-5585) to put into a 2mL eppendorf  
5. Dissolve palmitic acid with 100µl NaOH (10N) and vortex vigorously 
6. Add palmitic acid into preheated medium while stirring. (note; it will precipitate) 
7. Pour into falcon tube, protected from light  
8. Incubate in 50°C water bath for 4+ hours while shaking at 150-200rpm 
9. After the incubation period, filter solution to get chunks out using a 10mL syringe and 
sterile strainer  
10. pH to 7.4 
11. Aliquot solution and store at -20°C 
 
11.1.3. Determination of FFA using Wako Pure Chemicals HR Series NEFA –HR Kit 
1. Dissolve Reagent A into Solvent A 
 4.1mg of Reagent A per 1mL of solvent A (calculate total volume you need for 
samples and standards) 
2. Add 0.5mL of Reagent A solution into each cuvette and incubate for 5 min at 37°C 
3. Dissolve Reagent B into Solvent B 
 10.6mg of Reagent B per 1mL of solvent B 
4. Add 0.25mL of Reagent B solution into each cuvette and incubate for 5 min at 37°C 
5. Read at OD 550nm  
 
Cuvette 1mEq/L 
NEFA 
Std (µL) 
H20 
(µL) 
Reagent 
A Sol. 
(mL) 
I 
N 
C 
U 
B 
A 
T 
E 
Reagent 
B Sol. 
(mL) 
I 
N 
C 
U 
B 
A 
T 
E 
Optical 
Density 
550nm 
NEFA Conc. 
(mEq/L) 
Blank - 12.5 0.5 0.25 0 (Ref) 0 
0 - 12.5 0.5 0.25 0 0 
Low Std 6.25 6.25 0.5 0.25 read 0.5 
Mid Std 12.5 - 0.5 0.25 read 1.0 
High 
Std 
25 - 0.5 0.25 read 1.97 
Sample 12.5 - 0.5 0.25 read TBD 
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11.1.4. Palmitate Oxidation Buffers 
Seth Buffer (pH-7.4) 
300mM Sucrose 
2mM   EDTA 
10mM  Tris-HCL 
 
Reaction Mixture (pH-7.4) 
150mM  Sucrose 
5mM   MgCl2 
30mM   KCl 
30mM   Potassium phosphate buffer 
2mM   EDTA 
2mM   ADP 
15mM   Tris-HCL 
1%   BSA 
0.75mM  Palmitate 
1mM   Carnitine  
0.025mM  CoA 
0.2µCi/ml  [1-14C] Palmitic acid 
 
11.1.5. Palmitate Oxidation Protocol 
1. Following extraction, weigh tissues (~100mg muscle, ~100mg BAT, ~300mg WAT) and 
place into 200µl of ice-cold SETH buffer 
2. Depending on weight of tissue, add additional SETH buffer to yield a 20-fold (wt/vol) 
dilution 
3. Homogenize solution in an ice-cold Potter-Elvehjen glass homogenizer for approx. 30 
seconds 
4. Take 400µl of tissue homogenate and pipette into plastic scintillation vial containing 
1.6mL of reaction mixture 
5. Place isolated well containing loosely folded piece of filter paper inside of scintillation 
vial and cap using rubber stopper 
6. Include 2 blanks and 2 totals 
7. Gasify each scintillation vial for approx 1 minute, and incubate for 1 hour at 37°C 
8. After 1 hour, add 200µl (1:1, vol/vol) 2-phenylethylamine/methanol onto loosely folded 
filter paper in the center of the well, and 200µl of H2SO4 (5N) to acidify media. 
9. Incubate for 1 hour at 37°C 
10. Collect filter papers and transfer to corresponding scintillation vial containing 10mL of 
ECOLITE+ liquid scintillation cocktail (MP Biomedicals Cat #01882475) and place in 
scintillation counter for radioactivity counting 
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11.1.6. Western Blotting Buffers  
10x Running Buffer (pH- 8.3) 
30.34g  Tris base 
144g  Glycine 
10g  SDS 
Dissolve contents in 1L of ddH20 and store at room temperature. 
 
1x Running Buffer (pH- 8.3) 
10%  10x Running buffer 
90%  ddH20 
Mix solutions and store at room temperature. 
 
10x Transfer Buffer (pH- 8.3) 
30.3g  Tris base 
144g   Glycine 
Dissolve contents in 1L of ddH20  and store at room temperature. 
 
1x Transfer Buffer (pH- 8.3) 
10%  10x Transfer buffer 
20%  Methanol 
70%  ddH20  
Mix solutions and store at -20°C prior to use. 
 
10x Wash Buffer  
60.57g  Tris base 
87.66g  Sodium Chloride (NaCl) 
Dissolve contents in 1L of ddH20, store at room temperature. 
 
1x Wash Buffer 
10%   10x Wash buffer 
90%  ddH20  
Add 500µl/L of Tween-20 and NP-40. 
Mix solutions and store at room temperature. 
 
Blocking Buffer 
3% BSA (w/v: 1.5g/50mL)  
Dissolve in 1x Wash buffer, store at 4°C. 
 
Antibody (Ab) Buffer 
1° Ab- 1part blocking buffer + 2 parts wash buffer + 0.02% NaAzide (stock in ddH20) 
2°Ab- 1part blocking buffer + 2 parts wash buffer (NO NaAzide).  
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Typically 1:1000-1:5000 dilution is appropriate for an Ab, may vary depending on how good the 
signal is.  
 
Resolving gl Tris Buffer (1.5M) (pH-8.8) 
90.86g/500mL ddH20 
 
Stacking gel Tris Buffer (0.5M) (pH-6.8) 
30.3g/500mL ddH20 
 
10% APS Solution 
10% (w/v) Ammoniumperoxide Sulfate in ddH20. 
Use 0.1g/mL 
Store at -20°C.  
 
10% SDS Solution 
10% (w/v) Sodium dodecylsulfate in ddH20 
Use 1g/10mL 
Store at room temperature. 
 
Lysis Buffer for Protein Determination prior to Western blot 
 
Reagent Concentration/MW 
NaCl 135mmol/L (MW=58.44) 
MgCl2 1mmol/L (MW=203.3) 
KCl 2.7mmol/L (MW=74.55) 
Tris (pH 8) 20mmol/L (MW=121.14) 
Triton 1%  
Glycerol 10%  
Prepare lysis buffer stock and store at -20°C. Aliquot desired volumes and add 
protease(cOmplete ULTRA Tablets) and phosphatise (PhoStop) inhibitors just prior to use.  
 
Laemmli Sample Buffer (2x)- (Bio-Rad, Cat#161-0737) 
Per 1mL: 950µl of 2x Laemmli sample buffer 
     50µl β-Mercaptoethanol 
Store at room temperature. Dilute the sample (1 in 2) with sample buffer and boil for 5min.  
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11.1.7. Preparation of tissue lysates: 
1. After extraction, tissues are snap frozen and stored at -80°C. 
2. Weigh tissues and add to 250µl lysis buffer. (~20mg skeletal muscle, ~70mg BAT, 
~200mg WAT). 
3. Homogenize tissue. Keep on ice as much as possible to avoid heating up the sample. 
4. Centrifuge homogenate for 5min at 13,000rpm at 4°C.  
5. Remove middle aqueous protein-rich layer and place in a fresh microtube.  
6. Add 100µl lysis buffer to residual fat cake and pellet for additional extraction if 
necessary. If so, repeat steps 3-5. 
7. Centrifuge extracted sample for 1min at 13,000rpm at 4°C and transfer to a fresh 
microtube. Discard any residual cell debris. 
8. Take an aliquot from each sample for protein determination by the Bradford method. 
9. Dilute sample with 2x Laemmli sample buffer (1:1 v/v), vortex well and boil samples for 
5min. 
10. Samples can be used immediately for western blots or stored at -80°C. 
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11.1.8. Western Blotting Protocol 
Preparing the Gel/Gel Recipes 
 
Note: Use low % acrylamide gel when probing for large proteins, and  a higher % acrylamide gel 
for smaller proteins.  
 
Resolving Gel  
RESOLVING GEL  2 gels (8%) 2 gels (10%) 
ddH20 9.4 mL 8.2 mL 
30% Acrylamide (37:5:1) 5.4 mL 6.6 mL 
Tris-HCL (0.5M, pH 6.8) 5 mL 5 mL 
10% SDS 0.2 mL 0.2 mL 
Temed 20 µL 20 µL 
10% APS 100 µL 100 µL 
Add APS and Temed immediately prior to pouring the gel into plates. Pipette a thin layer of 
Isopropanol over the top of the gel to prevent resolving gel from drying out. Allow gel to set 
(approx. 20min).  
 
Stacking Gel  
STACKING GEL (4%) 2 gels (10mL) 
ddH20 6.1 mL 
30% Acrylamide (37:5:1) 1.3 mL 
Tris-HCL (0.5M, pH 6.8) 2.5 mL 
10% SDS 0.1 mL 
Temed 10 µL 
10% APS 50 µL 
Once the resolving gel is set, pour out Isopropanol and carefully blot excess with filter paper. 
Pour stacking gel on top of resolving gel. Put combs in place. Allow gel to set (approx. 20min).  
 
Running the Gel 
1. Take samples out of -80° freezer and place on ice. 
2. Place gels into tanks, and add 1x running buffer to fill the tank. 
3. Once samples have thawed, spin in centrifuge for a few seconds.  
4. Take out combs and pipette 7µL Bio-Rad protein ladder.  
5. Add samples into each well accordingly. 
6. Top up running buffer to make sure tank is full. 
7. Match electrodes up-black to black and red to red. 
8. Turn on the voltage for 60V for 2min, then turn it up to 110V for approx. 1.5hours until 
dye runs off the gel. 
9. At this point, you can prepare 1x transfer buffer. Once transfer buffer is well mixed, 
cover with parafilm and place in the -20°C freezer until ready for transfer. 
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Transferring the Gel onto a membrane 
1. Fill Pyrex dish with cold transfer buffer. 
2. Cut out equal sized membranes and dip in methanol to activate. Also cut out equal sized 
filter papers and prepare the appropriate number of foam pads. 
3. Place membranes in transfer buffer after activation. 
4. Once dye has run off the gel, remove the gels from tank and soak in transfer buffer. 
Carefully remove glass plates. Cut off and discard combs of the gel. Loosen gel from the 
glass plate with scraper. Allow to sit in transfer buffer. 
5. In the pyrex dish, place the black side of the cassette on the bottom, and place two 
foam pads and 3 filter papers on top. Ensure there are no bubbles. 
6. Carefully place gel on top of filter paper and use the roller to get any air bubbles out. 
Make sure gel is in the correct orientation so that the ladder will end up on the left side 
of the membrane when removed.  
Note: transfer runs from negative (black) to positive (red). Always ensure proteins will 
run from gel to the membrane.  
7. Carefully place the membrane on top of the gel and roll out any bubbles. 
8. Place 3 more filter papers on top and roll out any bubbles.  
9. Add one more foam pad and roll out any bubbles.  
10. Carefully close sandwich and place into transfer tank. Make sure black matches black 
and red matches red. 
11. Place iced pack in tank to keep buffer cold. Attach lid by matching electrodes- black to 
black, and red to red. Surround transfer tank with ice to keep cold.  
12. Turn on transfer at 120V for 2.5 hours or at 60V overnight.  
13. Check on temperature throughout transfer time to ensure no overheating.   
 
Probing the membrane 
1. Prepare containers to hold blocking buffer for each membrane, approx. 10mL. 
2. Once transfer has finished, open cassettes and quickly place membranes in containers 
with blocking buffer. 
3. Allow the membranes to surf in the blocking buffer for 1hr at room temperature. 
4. Pour out blocking buffer and add 1°Ab.  
5. Incubate overnight at 4°C. Ensure containers are fully sealed to avoid evaporation. 
6. The next day, remove 1°Ab and wash membranes 5x for 10min each with 10mL 1x wash 
buffer to rid the membrane of any unbound Ab. 
7. Add 2° Ab and allow membranes to surf for 1hr at room temperature.  
8. Remove 2°Ab and wash membranes 5x for 10min each with 10mL 1x wash buffer to rid 
the membrane of any unbound 2°Ab. 
9. Membranes are ready for developing 
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Developing the membrane 
1. For each membrane, use 3mL chemiluminescence (Millipore Luminata Forte Western 
HRP Substrate, Cat # WBLUF0500 ) per membrane and incubate for 3 minutes.  
2. Dip membranes into ddH20 to rinse and place on transparency inside cassette.  
3. In the darkroom, expose film for desired time. 
4. Place film in developer for a few seconds until signal appears. Dip into water and to stop 
the reaction, place in fixer solution. Ensure ample fixing time.  
5. Rinse with water and allow to dry.   
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11.2. Appendix B: Published Work 
11.2.1. Copyright Permission 
 
 The Journal of Biological Chemistry is a part of the American Society of Biochemistry and 
Molecular Biology (ASMBM). The ASMBM automatically grants original authors the use without  
requiring copyright permission request to do the following:  
 reuse an article in a thesis and/or dissertation 
 reproduce an article, reuse a figure, photo and/or table  
 present the work orally in its entirety 
 
Further information can be obtained from the ASMBM copyright permission policy online at: 
http://www.jbc.org/site/misc/Copyright_Permission.xhtml 
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